Delivering Excellence in Women's Health by University of Tennessee Health Science Center

Prepared by Giancarlo Mari, MD, MBA, FACOG, FAIUM Professor and Chair and the Department of Obstetrics & Gynecology (2018)

DELIVERING EXCELLENCE IN WOMENâ&#x20AC;&#x2122;S HEALTH The University of Tennessee Health Science Center Department of Obstetrics & Gynecology

Special thanks to: Randy Conway Adam Gaines David Glore LaTanya Spikenard Julienne Watkins

DELIVERING EXCELLENCE IN WOMENâ&#x20AC;&#x2122;S HEALTH Department of Obstetrics & Gynecology Prepared by Giancarlo Mari, MD, MBA, FACOG, FAIUM, Professor and Chair and the Department of Obstetrics and Gynecology (2018)

Our Mission The mission of the Department of Obstetrics and Gynecology at the University of Tennessee Health Science Center is to bring the benefits of the health sciences to the achievement and maintenance of human health with a focus on the citizens of Tennessee and the region by providing an integrated and self-sustainable program of education, research, clinical care, and public service.

Table of Contents Delivering Excellence.....................................................................................................2 History of Leadership.................................................................................................... 4 Department of Obstetrics and Gynecology......................................................... 8 Map of Clinics.................................................................................................................. 12 Education in OB/GYN..................................................................................................14 Residency Program....................................................................................................... 18 Fellowship Programs.................................................................................................... 21 OB/GYN Staff................................................................................................................. 23 Quality Improvement Programs.............................................................................. 24 Gynecology and OB Clinic........................................................................................ 32 Labor and Delivery....................................................................................................... 33 Maternal Fetal Medicine Division............................................................................34 High Risk Clinic.............................................................................................................. 35 Infectious Disease Section........................................................................................36 Center for High-Risk Pregnancies ......................................................................... 37 Ultrasound....................................................................................................................... 38 The Le Bonheur Fetal Center...................................................................................39 In-Utero Intervention Team...................................................................................... 40 IUGR Clinic.......................................................................................................................42 Opioid Maintenance Clinic.........................................................................................43 (West Memphis Regional) Perinatal Center........................................................44 Reproductive Genetics...............................................................................................45 Center for Reproductive Endocrinology and Infertility.................................46 Certified Nurse Midwives...........................................................................................48 Gynecologic Oncology Division..............................................................................49 Minimally Invasive Gynecology Surgery Center................................................50 Urogynecology Division.............................................................................................. 51 Pediatric and Adolescent Gynecology Clinic..................................................... 52 Menopausal Clinic......................................................................................................... 53 Center for HPV and Dysplasia ................................................................................54 Biostatistics and Research........................................................................................ 55 St. Jude Childrenâ&#x20AC;&#x2122;s Research Hospital .................................................................56 Regional One Health.................................................................................................... 57 OB/GYN Faculty and Fellows................................................................................... 58 Publications and Presentations (2016â&#x20AC;&#x201C;2018).....................................................64

All qualified applicants will receive equal consideration for employment and admissions without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity, age, physical or mental disability, or covered veteran status. Eligibility and other terms and conditions of employment benefits at The University of Tennessee are governed by laws and regulations of the State of Tennessee, and this non-discrimination statement is intended to be consistent with those laws and regulations. In accordance with the requirements of Title VI of the Civil Rights Act of 1964, Title IX of the Education Amendments of 1972, Section 504 of the Rehabilitation Act of 1973, and the Americans with Disabilities Act of 1990, The University of Tennessee affirmatively states that it does not discriminate on the basis of race, sex, or disability in its education programs and activities, and this policy extends to employment by the University. Inquiries and charges of violation of Title VI (race, color, national origin), Title IX (sex), Section 504 (disability), ADA (disability), Age Discrimination in Employment Act (age), sexual orientation, or veteran status should be directed to the Office of Equity and Diversity (OED), 910 Madison Avenue, Suite 826, Memphis, Tennessee 38163, telephone 901-448-7382 (V/TTY available). Requests for accommodation of a disability should be directed to the ADA Coordinator at the Office of Equity and Diversity. R073228051(001-190481)

DELIVERING EXCELLENCE Germantown, Kirby, TriState, and Tupelo and Clarksdale in Mississippi. We are now expanding to Chickasaw Gardens (Figure 1). Finally, our midwifery program continues to expand in the community, and delivers babies at Regional One Health.

The Department of Obstetrics and Gynecology (OB/ GYN) at the University of Tennessee Health Science Center (UTHSC) has undergone numerous changes in the past 10 years. Since 2008, the department has grown significantly, and it is now one of the most successful practices in the university.

INFANT MORTALITY IN MEMPHIS

We have come a very long way. In patient care, we have developed protocols on Labor and Delivery, started a quality program in all of our facilities, opened the Fetal Center at Le Bonheur Children’s Hospital, created an internal Reproductive Endocrinology and Infertility (REI) Division, started an in vitro fertilization (IVF) program, launched an ovarian preservation program, opened the Center for High-Risk Pregnancies (CHRP) adding an internal Minimally Invasive Gynecologic Surgery (MIGS) Division, and opened a substance abuse clinic. We are growing our practice throughout Memphis and the surrounding area. We are launching several new clinics: menopause, multiple gestation, and intrauterine growth restriction (IUGR). We will continue developing countless measures designed to push our standard of patient care further toward excellence.

Until a few years ago, the chances of a child born in the Memphis area reaching his or her first birthday were comparable to those of a child born in a third-world country. In fact, the United States has lagged far behind other world nations. The U.S. recently ranked 30th in infant mortality, which is a startling statistic, considering that approximately 17 percent of the U.S. gross domestic product is spent on health care – one of the top health care expenditures of any nation in the world. The infant mortality rate (defined as the number of infant deaths per thousand live births before reaching the age of one) is often used as an indicator of the level of health of a society. Several factors contribute to high infant mortality. Low birth weight and congenital anomalies are the top two causes of death for infants, both neonatally (from birth to four weeks of age) and postnatally (four weeks to a year).

Our department is one of the top clerkships for UTHSC medical students. Our clerkship student satisfaction is among the top in the United States. We have gone from scrambling spots, to becoming one of the top residency programs in the country. We have developed two approved ACGME fellowships.

Steve J. Schwab, MD, UTHSC chancellor, recruited me to Memphis in 2008. I partnered with Ramasubbareddy Dhanireddy, MD, chief of the Neonatal Intensive Care Unit at Regional One Health and at Le Bonheur. We have worked closely together for the past 10 years. Our main goal was to be part of a team that had the intent of decreasing the infant mortality rate in Memphis. The most striking result is that following the beginning of our program in 2008, the infant mortality and composite neonatal morbidity and mortality for very low birth weight infants in our hospital decreased from 20% above the expected to 20% below the expected, rate (Vermont Oxford Network data).

The department has developed an educational program (simulation program) called Obstetrical Feasible Approach to Simulation Training (OB F.A.S.T.). We have trained over a thousand medical providers in the U.S., and have branched to China (Zhenghzou University in the Henan Province). Our faculty’s research has changed the standard of care in several areas of obstetrics and gynecology. For example, the standard of using ultrasound to diagnose fetal anemia was a result of research done by our doctors. This technique has replaced the use of invasive and risky procedures such as amniocentesis and cordocentesis which carry a high risk of fetal mortality, and it has become the global standard of care. Our faculty has also pioneered the use of the nifedipine for preterm labor in the United States and the use of glucose in the amniotic fluid to diagnose chorioamnionitis. Through their efforts and research, they have also contributed to the decrease of infant mortality in Memphis.

The changes made in the UTHSC Department of Obstetrics and Gynecology, along with efforts countywide, have helped to reduce the infant mortality rate in Shelby County. Although the rate is trending downward, there is still work that needs to be done. The department will continue to collaborate with other obstetricians and hospitals in Memphis and the surrounding areas to improve upon our success, further develop innovative programs, provide educational opportunities and community outreach, and help children live to – and celebrate – their first birthdays.

The department, while based out of Regional One Health, has also improved community service with outreach programs at off-site locations including Memphis Health Center, Hollywood Healthloop Clinic, Baptist Women’s Hospital, Le Bonheur Children’s Hospital, Methodist

—2—

Giancarlo Mari, MD, MBA, professor and chair, Department of Obstetrics and Gynecology

Photo by Larry Kuzniewski

History of Leadership 1911-2018

The University of Tennessee Health Science Center was founded in 1911. Four faculty members led obstetrics and gynecology until 1919.

Obstetrics

Gynecology

Dr. James Lindsay Andrew

Dr. James Metcalf Maury

Dr. Percy Walthall Toombs

Dr. Frank David Smythe

In 1920, the first chief of the Division of Obstetrics and Gynecology was named. Dr. James Metcalf Maury. He served at division chief until 1933. The following is a list of the subsequent division chiefs.

Division Chiefs Dr. William Thomas Pride (1934 – 1945) Dr. Frank Edward Whitacre (1946 – 1954) Dr. Philip C. Schreier (1955 – 1966)

In 1967, the first chair of the Department of Obstetrics and Gynecology was named. Dr. Stewart Fish. He served as chair until 1974. These department chairs followed him.

Chairs of the Department Dr. Preston V. Dilts, Jr. (1975 – 1985) Dr. George M. Ryan, Jr. (1986) Interim Chair Dr. Joe Leigh Simpson (1987 – 1993) Dr. Frank Ling (1994 – 1995) Interim Chair Dr. Frank Ling (1995 – 2003) Dr. Owen Phillips (2004 – 2005) Interim Chair Dr. Veronica Mallett (2005 – 2009) Dr. Giancarlo Mari (2009 – 2010) Interim Chair Dr. Giancarlo Mari (2010 – Present)

Department of

Obstetrics and Gynecology Chair: Giancarlo Mari, MD, MBA

GYNECOLOGY

MATERNAL-FETAL MEDICINE

Roberto Levi-D’Ancona, MD, Director Pedro Argoti, MD Kerri Brackney, MD Laura Grese-Willingham, MD Pallavi Khanna, MD Linda Moses, MD Owen Phillips, MD Ramona Phinehas, MD Ashekia Pinckney, MD Marina Santa-Cruz, MD Claudette Shephard, MD

Mauro Schenone, MD, Director Molly Houser, MD Giancarlo Mari, MD Norman Meyer, MD, Vice-Chair Danielle Tate, MD Renee Abdu, NP Ebony Smith, NP Fernand Samson, MFM Fellow Michael Aziz, MFM Fellow Jennifer Barr, MFM Fellow

MIDWIVES

RESEARCH TEAM

EDUCATION

Linda Moses, MD, Director Davin Johnson, CNMW Breia Loft, CNMW Meghan Madea, CNMW Amber Peasley, CNMW Amanda Williams, CNMW Edna Tucker, CNMW

Chi-Yang Chiu, PhD Trish Goedecke, MS Annette Hickerson, RN Anna Joy Rogers, DrPH Chelsea McGee, RN

Kitty Cashion, RN Nancy Ruch, RN

CLINICAL FACULTY (MD) = 114

—8—

MINIMALLY INVASIVE GYNECOLOGY SURGERY

REPRODUCTIVE GENETICS Owen Phillips, MD, Director

Ben Abdu, MD, Director

REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY

PEDIATRIC ADOLESCENCE Claudette Shephard, MD, Director

Laura Detti, MD

UROGYNECOLOGY

GYNECOLOGY ONCOLOGY

Gregory Portera, MD

Todd Tillmanns, MD, Director Mark Reed, MD Linda Smiley, MD Laura Daily, GYN ONC Fellow Tiffany Redfern, GYN ONC Fellow Michael Ulm, GYN ONC Fellow

ADJUNCT FACULTY

ADMINISTRATION

Wendy Likes, PhD Nina Sublette, PhD Diane Todd-Pace, PhD

Randy Conway, Director Gwenna Doty Eula Ellington David Glore Linda Gray

EMERITUS Daniel Martin, MD

—9—

Paula Odom LaTanya Spikenard Martha Velez Julienne Watkins

Department of Obstetrics and Gynecology Clinical Faculty John F. Albritton, MD Lanetta Anderson, MD Peter L. Ballenger, MD Lea Bannister, MD Laura Bishop, MD Melrose I. Blackett, MD Michael S. Bronstein, MD Butawan-Ali Dominique, MD Sharon Ann Butcher, MD Judi Lynn Carney, MD Belvia Carter, MD Todd Chappell, MD Heather Chauhan, MD Kira Cooley, MD Kristi Cole, MD Sam J. Cox III, MD Thomas Crenshaw, MD Crista Crisler, MD Rushelle Jones Cyrus, MD Joseph Dewayne, MD Heather, Donato, MD Betty Jo Dulaney, MD Barbara Duncan-Cody, MD Michael L. Edelson, MD Brandon Edwards, MD Stephen Ehiremen, MD Adam ElNaggar, MD Laura Engbretson, MD Rye E. Estepp, MD Maria Fernandez, MD Helena Geissler, MD G. Aric Giddens, MD M. Andrea Giddens, MD Vanessa Givens, MD Deidrea Grandberry, MD Thomas L. Gray, MD Lindsay Green, MD Thomas D. Greenwell, Jr., MD

Donald L. Hamby, MD Brenda Hardy, MD Laura Haskins, MD Regina G. Healy, MD Candace Hinote, MD Riad Homsi, MD Penn Q. Joe, MD Mary Katherine Johnson, MD M. Leigh Keegan, MD A. Franklin Kennedy, MD T. Franklin King, MD Alok Kumar, MD Sanjeev Kumar, MD Susan Lacy, MD Joseph K. Lawrence, MD Edward Lazar, MD Daniel Lee, MD Helen Lee, MD Torrance Lewis, MD Bo Charles Li, MD Sherri Li, MD Katherine Liu, MD Diane Long, MD Carol Lynn, MD Shannon Ridley Malone, MD Fazal Manejwala, MD Elizabeth Mann, MD Kyle Patterson Martin, MD Leslie T. Mayo, MD Jane McAdory, MD Mitchell McAlister, MD Mary N. McDonald, MD Corey Shane McGlothan, MD Christine S. Mestemacher, MD Kristin M. Miller, MD Claudia L. Moise, MD Dwight M. Moore, MD Yvonne Sims Moore, MD

— 10 —

Jason Mullenix, MD Susan G. Murrmann, MD Paul David Neblett, MD Kingsley Oraedu, MD Audrey Page, MD Shweta Patel, MD James K. Patterson, MD Rushton E. Patterson, MD George Peeler, MD Paula Pilgrim, MD Rada John, MD Cheston M. Reed, MD Rouselle, Dionne, MD Ceylon Rowland, MD Jessica Ruffin, MD Jack C. Sanford, Jr., MD Joseph Santoso, MD Melvinie Seymore, MD Michael L. Stack, MD W. David Stinson, MD Thomas G. Stovall, MD Margaret Z. Summitt, MD Herbert Taylor III, MD Kristal Taylor, MD Indu Tejwani, MD Cory R. Tinker, MD Tanja L. Todd, MD Leah Tonkin, MD Arthur Townsend IV, MD Jennifer L. Valli, AASECT Hemanth Veluswamy, MD Sarah Wallett, MD Jason Williams, MD James A. Wilson III, MD George F. Wortham III, MD Alicia Wright, MD Robert L. Yates, MD Carlos Zavala, MD

Department of Obstetrics and Gynecology Residents 2018-19 = 33 PGY-4

PGY-3

Patrick Blackburn, MD Mallorie Hoover, DO Heather Jones, MD Florene Dixon Odulana, MD Robert Roman, MD Nicole Van de Velde, MD Heather Wherry, MD

Alexa Calfee, MD Mary Christiansen, MD Katherine Dorsett, MD Jennifer Gordon, MD Elizabeth Lane, MD Caiyun Liao, MD Naiha Mussarat, MD Irene Peregrin-Alvarez, MD Eric Rios-Doria, MD

PGY-2

PGY-1

Morgan Bankston, MD Faith Creekmore, MD Jane Elyse Henkel, MD Pouran Malekzadeh, MD Claudio Schenone, MD Elena Siani, MD Lea Elizabeth Stokes, MD Elizabeth Tarsi, MD

Derek Dean, MD Deepa Etikala, MD Justin Lewis, MD Joshua Morris, MD Michael Pezzillo, MD Marieme Racine, MD Eduardo Grimaldi, MD Paula Vasichko, MD Naixin Zhang, MD

— 11 —

Clinic Locations in the Tri-State Area (TN, MS, AR) 69 40

8 Chelsea Ave

N. F

ron t

Warford St

N. McLean Blvd

Ave

N. MWatkins St

els

N. Hollywood St

Chelsea Ave

e Av

s ck

Jackson Av e

Summer Ave Summer Ave

Popla r

S. 3rd St

S. Bellevue Blvd

Central Ave

Ave

Central Ave

N. Perkins Rd N. Perkins Rd

Walnut Grove

Central Ave

Warning Rd

N. Graham St

Av e

High Point Terrace

Cooper St

lar

Union Ave

N.Hignland St

Po p

Madison Ave

N.Holmes St

Ave

E. Pkwy

St S. 2

Union

Tillman St

Poplar Ave

Jefferson Ave Madison Ave

Summer Ave

Sam Cooper Blvd

S. Goodlett St

2 3 1

Southern Ave

Park Ave

Cliff Gookin Blvd

240

ve oA sot

Clarksdale, MS

Rd 261

Gr ah

S. Eason Blvd

10 S. Globster St

ez Tr ac eP De

New A frica R d

St te Sta

Na tc h

55 N.

S. Thomas St

55 kw y

Bissell Dr

W. 2nd St

E. Lee Dr

Friars

W. Lee Dr

Graham Dr

Point Rd

Tupelo, MS

— 12 —

1. Regional One Health | The Med

5. St. Jude Children’s Research Center

9. Primary Care Specialists

1. Regional One Health

er Av e

2. Le Bonheur Children’s Hospital Su m

3. Memphis VA Medical Center 4. Harbor of Health* 5. St. Jude Children’s Research Hospital

Av e

6. Memphis Health Center Su

7. Regional One Health South Third Clinic 8. Hollywood Health Loop Center 9. Primary Care Specialists* 10. Tri-State Community Health Center

N. PMendenhall Rd

240

11. Regional One Health East Memphis 12. Methodist Le Bonheur Germantown

Walnut Grove

s y’ re

13. B aptist Memorial Hospital for Women

N. White Station Rd

240

Kirby Pkwy

S. White Station Rd

Park Ave

Mt. Moriah Rd

14. U T Center for High Risk Pregnancies

Wolf R iver B lvd

Popla r

15. T he Women’s Clinic Clarksdale. MS

Riverdale Rd

Rd N. Perkins

Shady Grove

16. O bstetrics-Gynecology Associates | Tupelo, MS

Ave

240

iah

ll M

ori

ris

11 Pk wy

S. Germantown Rd

*Future Locations

— 13 —

13. Baptist Memorial Hospital for Women

Education in Obstetrics and Gynecology Clerkship Program

gynecologic oncology, minimally invasive, and general gynecological surgery. Additionally, the Center for Healthcare Improvement and Patient Simulation (CHIPS) recently opened a worldclass facility on campus, which offers simulation training using the Vimedix OB/GYN unit as well as Ultrasound, PelvicSim, and PelvicHyst virtual trainers.

In the Department of Obstetrics and Gynecology (OB/GYN) at UTHSC, we are focused on and dedicated to the education of the next generation of practicing professionals. Residents and medical students, as a team, rotate through the department and gain valuable insight from UT physicians. Each year, UTHSC faculty, nurses, and residents train more than 160 medical students in clerkships throughout the university. Approval ratings place the OB/GYN Clerkship among the top in the nation.

Clerkship Director Roberto Levi-D’Ancona, MD and Assistant Clerkship Director Pallavi Khanna, MD, oversee the education of each medical student during his or her time in OB/GYN to ensure the complete and successful training of each medical student.

During their OB/GYN rotation, students learn about obstetrical and gynecological issues ranging from labor and delivery to high-risk pregnancy, reproductive endocrinology,

— 14 —

EDUCATIONAL EXPERIENCES IN OB/GYN CLERKSHIPS Obstetrics-Gynecology/Women’s Health

Likert Average (1=Poor / 4+Excellent) 3.8

UTHSC 3.6

All Schools

3.4

3.2

3.0

2.8

2.6 2011

2012

2013

2014

2015

2016

2017

Year of Graduation

QUALITY OF CLERKSHIPS Obstetrics-Gynecology/Women’s Health

Good + Excellent (Like Sum) 100

UTHSC All Schools 80

20 2011

2012

2013

2014

2015

Year of Graduation — 16 —

2016

2017

RESIDENTS PROVIDED EFFECTIVE TRAINING DURING CLERKSHIP Obstetrics-Gynecology/Women’s Health

Likert Average (1=Strongly Disagree / 5=Strongly Agree) 5.0

UTHSC All Schools

4.5

4.0

3.5

3.0

2.5 2011

2012

2013

2014

2015

Year of Graduation

— 17 —

2016

2017

Residency Program UTHSC faculty also educate new MDs in the department’s Residency Training Program, under the leadership of Program Director Claudette Shephard, MD, and Associate Program Director Danielle L. Tate, MD. The program’s mission is to educate residents in the entire breadth of the discipline of obstetrics and gynecology, and to foster a lifelong commitment to the promotion of women’s health care.

Care Unit, the Neonatal Intensive Care Unit, Urogynecology, and Ambulatory Services. It is a training experience aimed at providing residents with all the skills needed to succeed in any OB/ GYN situation. While training is based at Regional One Health, residents gain experience in hospitals across the Mid-South, including Baptist Women’s, Methodist, and the Memphis VA Medical Center. Residents in their third year are given the opportunity to present original research before a group of instructors and peers at the Annual Resident Research Forum. National and international guest lecturers are invited to judge the research each year. The diversity among our patients, students, residents and faculty is truly an asset. We have a supportive family of residents and faculty, in an environment that facilitates a balance of learning and living for the young physician, making this a very attractive place to train.

The Residency Training Program was first accredited at UTHSC in 1970. Today, the program welcomes nine new interns from a pool of more than 600 applications each year. As of 2018, the program has continued accreditation by the ACGME and has become one of the more desirable locations to undergo training in the country. One of the reasons for the success of the residency program is that it strives for excellence. Our residents come from all regions of the United States and international schools. The program searches for well-rounded students with superlative academic records, a passion for OB/GYN, and a drive to serve the underserved. Prospective applicants must be selfless, motivated, and compassionate, with an understanding of issues endemic to the Mid-South, and a determination to find answers in complicated cases.

Additionally, the department organizes the Fetal and Neonatal Imaging Conference and the Contemporary Issues in Obstetrics and Gynecology (CIOG) Conference, both national conferences. The annual CIOG Conference is targeted to generalists, residents, nurse practitioners, midwives, and primary care physicians. It is held in Destin, Florida, and 2019 marks the 33rd anniversary of this conference. National and international speakers participate in both of these conferences.

UTHSC OB/GYN residents, once accepted, rotate through Low-Risk Obstetrics, Benign Gynecology, Maternal-Fetal Medicine, Oncology, Reproductive Endocrinology and Infertility, the Surgery Intensive — 18 —

ACGME FACULTY SURVEY Faculty Supervision and Teaching

Teamwork

4 3

4.3

4.7

4.6

1 AY15-16

AY16-17

AY17-18

AY15-16

Educational Content

Resources

4.5

4.8

4.7

AY15-16

AY16-17

AY17-18

ACGME RESIDENT SURVEY Clinical Experience and Education 5 4

4.7

4.8

4.7

AY15-16

AY16-17

AY17-18

3 2 1 0

4.9

4.7

AY16-17

AY17-18

4.3

4.2

AY16-17

AY17-18

4.5

— 19 —

3.9

AY15-16

Residentsâ&#x20AC;&#x2122; Research Day 2018

Fellowship Programs

L to R: Michael Aziz – PGY 6, Jennifer Barr – PGY 5, and Fernand Samson – PGY 7

MATERNAL-FETAL MEDICINE FELLOWSHIP The MFM fellowship is one of the department’s crowning achievements in education. Many years of excellence have produced outstanding MFM physicians. The fellowship, governed by the American Board of Obstetrics and Gynecology until 2017, has been the only MFM fellowship in the entire state of Tennessee. Dr. Giancarlo Mari is the director of the MFM fellowship. More recently, the fellowship successfully transitioned to ACGME accreditation.

research, teach, and provide high-quality, subspecialty care. The program, based within the UTHSC College of Medicine and the Department of Obstetrics and Gynecology, serves Regional One Health in Memphis, as well as other affiliated practice sites, and the education of the fellows involves other academic departments and divisions, such as Neonatology, Pathology, Anesthesiology, and Genetics. Fellows learn to become effective consultants to OB/GYN generalists for women with complicated pregnancies, and to take an evidencebased approach to medicine.

The MFM fellowship Program at UTHSC develops clinician-scientists who are prepared to conduct

— 21 —

GYNECOLOGY ONCOLOGY FELLOWSHIP

Michael Ulm – PGY 7

Tiffany Redfern – PGY 5

The division has an ACGME accredited fellowship program that started in 2016. It consists of three fellows. A new fellow is accepted into the program annually. Dr. Todd Tillmanns is the director of the fellowship. The Gynecologic Oncology Fellowship Program at UTHSC develops clinician-scientists, who are prepared to conduct research, teach, and provide high-quality, subspecialty care.

UNIVERSITY OF TENNESSEE/REGIONAL ONE PHYSICIAN (UTROP) ULTRASOUND FELLOWSHIP The creation of the UTROP Ultrasound Fellowship represents one of the highlights in education in recent years. We have now graduated our two first ultrasound fellows. At the completion of the fellowship, our fellows have a solid foundation of knowledge and outstanding skills in prenatal ultrasound. Regarding education, our team has designed a well-structured curriculum that involves theory and practice sessions, ultrasound simulation, evaluation and feedback. We have also welcomed international visiting scholars interested in learning about our unit; the demand for such visits has increased over the years. Kerri Brackney, MD — 22 —

L to R: Eula Ellington, Jo Boddie, Linda Gray, LaTanya Spikenard, Randy Conway, Paula Odom, Martha Velez and Julienne Watkins

OB/GYN Staff

Quality Improvement Programs At Regional One Health, the Department of OB/ GYN has developed a quality improvement program in OB/GYN concentrated on labor and delivery (L&D). Team events play an important role in process improvement. Team events are divided into briefs, huddles, and debriefs.

Additional quality measures that are standard of care in L&D include the following:

Briefs are the planning process. All members of the team participate. One of these briefs is Team STEPPS (Strategies & Tools to Enhance Performance & Patient Safety), which occurs twice per day on L&D. Safety huddles are used for problem solving, usually in small groups. The lead physician and the charge nurse meet to discuss the plan for each patient. There are four huddles daily, scheduled every six hours on L&D. Debriefs are used to facilitate process improvement. Any team member can request a brief, huddle, or debrief.

•A n in-house gynecology team available for both obstetrical and gynecological emergencies

•A morning report sign-out system, where all obstetrical patients are discussed with faculty, residents, nurses, and students in a HIPAAcompliant room

•2 4-hour availability of Maternal-Fetal Medicine specialists •C ontinual communication between neonatology and obstetrics • Organized multi-disciplinary conferences •C lose partnership with anesthesiologists specialized in obstetrical care •W eekly didactics conferences for all residents and Maternal-Fetal Medicine fellows

— 24 —

•F etal heart rate monitoring present in all L&D areas

and international conferences, providing education to hundreds of healthcare providers around the world.

• Organized simulation training

The main site for OB F.A.S.T. is Regional One Health in Memphis. Every summer we also organize a simulation training in Sandestin, Florida. Between the two sites we have trained over 1000 providers. Our main site outside the United States is at Zhengzhou University in China. Dr. Genxia Li is the lead organizer of the course. The simulation course is held twice a year in China – April and September. The courses will continue until it will be considered useful for medicine in that country.

•A leadership program for L&D, with MFM physicians taking charge. Furthermore, the leaders of the L&D team have developed the OB F.A.S.T. (Feasible Approach to Simulation Training) Program, an evidence-based simulation program that has shown improvement in perinatal outcomes through an interdisciplinary team approach to training. Quarterly, all staff members including physicians, nurses, surgical technicians, anesthesia, and clerical staff, participate in hands-on simulation training. Simulations focus on common obstetrical situations as well as obstetrical emergencies that require superior teamwork. Drills are run with all team members taking on real-life roles with the goal of mastering skills that will assure optimal outcomes in actual events. These team leaders ensure that everyone working on L&D is up-to-date with current standards of care through continuing education lecture series as well. In recent years, the OB F.A.S.T. Program has expanded training to both national

With the advent of the UTHSC Center for Healthcare Improvement and Patient Simulation (CHIPS) Center, the L&D leadership plans to take quality of patient care delivery to even higher levels through continued education. The effort of the team has contributed to fulfillment of the department’s mission in patient care, education, community, and research.

— 25 —

Research Initiatives

— 27 —

The Role of the Department of Obstetrics and Gynecology at UTHSC/ROH in Decreasing the Infant mortality and composite morbidity and mortality in Memphis

During Observation, the opportunities we found for improvement were numerous. We realized that there were differing definitions for the same clinical conditions, and no protocols for management of common conditions. Most often, these conditions were managed by the obstetrician without input from the maternal fetal medicine specialist.

Infant mortality rate (IMR) is commonly accepted as a measure of the general health and well-being of a population. It is associated with a variety of factors, such as maternal health, quality of and access to medical care, socioeconomic conditions, and public health practices.

Many neonates were admitted to NICU at low temperatures, because of a lack of protocol. There was poor communication between obstetricians and neonatologists. There was no peer review of cases with complications; attendance at training conferences among the residents was poor. Until 2008, there were no structured rounds and no mandatory trainings.

Over an extended period of time, Memphis has had one of the highest infant mortality rates among U.S. cities. In 1932, the U.S. Census Bureau reported that Memphis had the highest IMR of any city of 100,000 or more people in the United States birth registration area (Oppenheimer E. Infant mortality in Memphis. Washington DC: Childrenâ&#x20AC;&#x2122;s Bureau Publication;1937). Until 2008, the infant mortality rates in some of the Memphis ZIP codes were comparable to those of a Third World country. More than 60 percent of the infant deaths in Memphis occur during the neonatal period.

The Awareness phase included meetings, discussions, and surveys for all involved with infant care at ROH. All acknowledged problems, sought improvement, and spread awareness of changes in progress. A SWOT (strengths, weaknesses, opportunities, and threats) analysis was conducted among L&D personnel. These phases led to Implementation, bringing the development of protocols, standardization of definitions, improved communication, recruitment of MFM specialists, and the initiation of a MFM fellowship.

Very low birth weight (VLBW) infants are a significant contributor to the high infant mortality in Memphis. They represent 2.5 percent of all live births in Shelby County, and account for 67 percent of infant deaths. Eighty-four percent of VLBW infant deaths occur during the neonatal period (Health at a Glance 2016: OECD Indicators. Organization for Economic Co-Operation and Development (OECD);2016). More than 50 percent of very low birth weight infants in Memphis are delivered at Regional One Health (ROH). The number of these infants at ROH has ranged from 3.5 percent to 5.5 percent of deliveries from 2004 to 2015; this is more than three times the national average and 1.5 times higher than the national average for African Americans.

Rounds on L&D increased from two to ten per 24hour period. The directors of MFM and neonatology began meeting daily. They standardized neonatal thermal support and resuscitation, including surfactant administration, and emphasized steroid use for pregnancies at risk of prematurity. Multidisciplinary meetings and mandatory trainings occurred frequently. The MFM team increased from three to nine, including faculty and fellows. OB F.A.S.T. was begun.

Beginning in June 2008, the Department of Obstetrics and Gynecology and the Division of Neonatology at ROH reorganized the perinatal program. Many changes developed in management of labor and delivery (L&D), and in communication among all teams involved. The changes were designed to improve obstetrical and neonatal care.

We evaluated the infant mortality and the composite morbidity and mortality rates five years before the beginning of our program (2004-2008) and seven years following it (2009-2015). The morbidity and mortality decreased from 20 percent above the expected to 20 percent below the expected. The results are reported in Table 1 and in figures 1-3 (Global Pediatric Health 2018;5:1-10).

Our new program included three overlapping phases: Observation, Awareness, and Implementation. The Observation phase examined the obstetrical and neonatal care provided at ROH.

These results have contributed with many other initiatives started by different teams to the decreased infant mortality in Memphis.

â&#x20AC;&#x201D; 28 â&#x20AC;&#x201D;

Unadjusted infant mortality and composite neonatal outcome (morbidity+mortality) rates and odds ratios at Regional One Health (ROH), Memphis Years

2004–2008

2009–2015

OR, 95% CI, p-value

n=1,124

n=1,240

2.8%

Infant Mortality N(%)

174 (15.5)

162 (13.1)

OR=0.82, 0.65-1.03, 0.0933

Morbidity and Mortality N(%)

626 (55.7)

544 (43.9)

OR=0.62, 0.53-0.73, <0.0001

n=number

Year Comparison 2005–2004

FIGURE 1

2006–2004

Comparison of composite infant morbidity-mortality rates of subsequent years to the baseline in 2004 at ROH. Odds ratios below 1 indicate reduction in odds of infant morbiditymortality. (From Global Pediatric Health 2018; 5: 1-10)

2007–2004 2008–2004 2009–2004 2010–2004 2011–2004 2012–2004 2013–2004 2014–2004 2015–2004 0.0

0.2

0.4

0.6

0.8

OR & 95% CI

— 29 —

1.0

1.2

Three Year Average 2004–2006

FIGURE 2

2005–2007

Standard risk adjusted mortality and composite morbidity ratio (SMR). The dots represent the mean; the bars represent the 95% confidence interval. The number one represents the expected mortality and composite morbidity as determined by the Vermont Oxford Network for our center. The SMR is calculated using a 3-year average. (From Global Pediatric Health 2018; 5: 1-10)

2006–2008 2007–2009 2008–2010 2009–2011 2010–2012 2011–2013 2012–2014 2013–2015

0.6

0.8

1.0

1.2

Standardized Mortality Ration & 95% CI

Variables Post Implementation

FIGURE 3

Antenatal Steroids

Multivariate logistic regression model showing the association between the covariates of interest and infant mortality over time. (From Global Pediatric Health 2018; 5: 1-10)

C-section

Surfactant Birth Weight (10g) Male Gender

Apgar Score

0.0

0.5

1.0

1.5

2.0

OR & 95% CI

— 30 —

2.5

The fetal middle cerebral artery PSV assessment has become the global standard of care for the diagnosis of the fetal anemia. A PSV value above 1.5 MOM in patients at risk indicates fetal anemia.

â&#x20AC;&#x201D; 31 â&#x20AC;&#x201D;

Gynecology and OB Division The majority of patients who deliver at Regional One Health receive routine prenatal care with us in our outpatient clinic setting. The Low-Risk Clinic is directed by Dr. Roberto Levi D’Ancona and co-directed by Dr. Ramona Phinehas, with a competent team of OB/GYN generalists. The clinic works in great coordination with the Maternal Fetal Medicine doctors to provide routine prenatal care, ultrasounds, and further antenatal surveillance based on the complexities of the needs of the patient.

and pap smears. We diagnose fertility problems, premenstrual syndrome, and menopause-related issues. We perform surgical procedures such as cesarean sections and hysterectomies; and other procedures such as colposcopies, to remove abnormal cells from the cervix. For women who have reproductive health conditions, such as endometriosis or fibroids, OB/GYN doctors here have mastered laparoscopic procedures as well. For reproductive health, visits start as early as age 13-15. Building a relationship with an OB/GYN physician is ideal even before pregnancy, so that we can provide the best possible treatment.

Another important role of this clinic is to diagnose and treat female reproductive health issues including sexually transmitted diseases, menstrual issues, diseases of the uterus, fallopian tubes and ovaries, and annual exams – with breast exams

In this clinic there are approximately 40,000 visits per year. This clinic is expanding to various communities in and around Memphis.

— 32 —

Labor and Delivery UTHSC physicians in the Department of Obstetrics and Gynecology (OB/GYN) deliver over 3,000 babies per year in Labor and Delivery (L&D) at Regional One Health. Attending physicians, residents, nurses, and private physicians work as a team to ensure that every patient is cared for, from pregnancy until six weeks postpartum, at one of the highest levels of care in the region. Although UTHSC physicians also perform deliveries for regular patients, their specialty is high-risk care. A multidisciplinary team of physicians and nurses are led by Director of Labor and Delivery, Norman Meyer, MD, PhD. Dr. Meyer and his team treat the most seriously ill patients from around the region, building trust and educating each and every patient.

Our L&D team ensure that all departmental safety initiatives are implemented and followed. Among these initiatives, patients are encouraged to carry their babies to at least 39 weeks of gestation. Physicians will also administer antenatal steroids to patients who are at risk of preterm delivery. Physicians and nurses meet at weekly intervals to discuss patient care and to ensure that every member of the team is committed to the same treatment plan. Twice each day at Team STEPPS, all attending physicians, residents, nurses, private physicians, midwives, chaplains, case managers, ante and postpartum nurses and technicians, anesthesiologists, pediatricians, obstetricians and clerks, meet to discuss their patientsâ&#x20AC;&#x2122; care.

Maternal-Fetal Medicine Division intervention and Doppler ultrasonography, as well as many other procedures.

The Maternal-Fetal Medicine (MFM) Division of the Department of Obstetrics and Gynecology at UTHSC is a multidisciplinary team of physicians, nurses, sonographers, dietitians, pharmacists and psychologists with one goal: taking care of pregnant women. Specifically, the division sees patients who are considered to be at risk of complication preceding pregnancy, during pregnancy, or immediately after birth.

The doctors of this division are world-renowned physician-scientists who lecture nationally and internationally on a range of topics. They have developed procedures that have changed the standard of care in prenatal diagnosis and intervention globally. Specifically, our MFM physicians have pioneered treatment for twin-to-twin transfusion syndrome, the use of nifedipine in the treatment of preterm labor, the use of glucose in the amniotic fluid to diagnose chorioamnionitis, surgical techniques such as salpingectomy during cesarean section, and ultrasound methods to assess fetal lung maturity and predict outcomes. They have developed a non-invasive method to diagnose fetal anemia with ultrasound, a method that has become a global standard of care.

The division is led by Dr. Mauro Schenone, director of Maternal-Fetal Medicine. Since 2008, the division is growing quickly – now being one of the most successful practices in the university’s health care system. It covers all high-risk pregnancy care at Regional One Health in Memphis, which includes more than 3,000 deliveries per year. In addition, it covers four other locations and has a referral base covering five states. Our area of influence continues to expand through a recently started outreach initiative to provide MFM clinic sessions to areas with limited access to larger cities, and without MFM services.

Our division is a ‘hands on’ MFM division. The skills of our MFM physicians allow them to lead multidisciplinary teams and to perform complex obstetrical surgeries including transabdominal cerclage, cesarean hysterectomies, dilatation and evacuation, among other procedures.

The division has more than 8,000 high-risk patient visits per year, and performs high-level ultrasound (approximately 15,000 per year) with 4-D ultrasound capability, fetal echocardiograms, first-trimester screening, prenatal diagnosis, genetic counseling, chorionic villus sampling, fetal arrhythmias, intrauterine transfusion for fetal anemia, fetal shunting procedures, in-utero

To stay current and continue to hone their skills, MFM physicians at UTHSC engage in regularly scheduled conferences at which they discuss complicated cases. Members of our division lead OB F.A.S.T., an innovative simulation program to improve safety and quality of care in labor and delivery. — 34 —

High-Risk Clinic Approximately one-half of the deliveries at Regional One Health are considered high risk. Women identified to be at high risk for maternal and/or fetal conditions are diagnosed and managed through our outpatient service at the High-Risk Clinic. The High-Risk Clinic is directed by Danielle Tate, MD, a board certified Maternal-Fetal Medicine specialist who completed her fellowship at the University of Tennessee Health Science Center. Her team covers all high-risk patients seen at the Regional One Outpatient Center and contributes to the training of UTHSC residents and students rotating in MFM. Together with a team of compassionate nurses, diabetic educators, social workers, residents, and fellows, specialists at the High-Risk Clinic provide diligent care to women with pregnancy disorders.

• Gastrointestinal disease • Preexisting cardiovascular conditions, such as cardiomyopathy or congenital cardiac lesions • Common and rare infectious diseases • Solid organ transplant (kidney, liver, etc.) • Abnormal prenatal laboratory tests, such as quadruple screen • Multiple pregnancy (twins, triplets, etc.) • Advanced maternal age • Preterm labor, preterm premature rupture of membranes, or risk of these conditions • Recurrent pregnancy losses • Morbid obesity

These disorders may include:

• Fetal growth restriction

• Hypertensive disorders including preeclampsia

• Fetal malformations (minor or lethal)

• Pregestational and gestational diabetes

Every pregnancy is monitored closely through frequent appointments, including not only clinic visits, but also antenatal testing and ultrasound sessions – all conveniently performed onsite.

• Thyroid and other endocrine disorders • Chronic renal disease • Blood disorders including anemia, hemoglobinopathies, and thrombosis

Infectious Disease Section Our Maternal-Fetal Medicine Infectious Disease (MFM-ID) Obstetric program provides care to women whose pregnancies are affected by infections such as HIV, hepatitis B, hepatitis C, cytomegalovirus, parvovirus, syphilis, tuberculosis, and other illnesses.

with St. Jude Children’s Research Hospital and Le Bonheur Children’s Hospital. Our rate of perinatal HIV infection is below the national average. After delivery, patients infected with HIV are offered contraception counseling and are referred to medical providers specializing in HIV. Children of our patients are followed by a team of pediatric infectious disease specialists from St. Jude Children’s Research Hospital.

HIV obstetric care is provided by a team led by MFM subspecialist Danielle Tate, MD, and nurse practitioner Nina Sublette, PhD. These providers possess specialized training in infectious diseases and are experienced in the care and use of HIV medications in pregnancy. The team is also composed of a group of licensed social workers and nurses who provide ancillary support to the patient throughout her pregnancy.

Pregnant patients who are infected with hepatitis B are evaluated to assess whether they are candidates for treatment to reduce neonatal hepatitis transmission. Patients whose pregnancies are complicated by other infectious conditions are also evaluated and receive individualized care according to their condition. All patients coming to our MFM-ID clinic are treated with the utmost compassion and confidentiality.

We provide new and state-of-the-art treatment with antiretrovirals, in accordance with current perinatal guidelines from the National Institutes of Health. Our program also functions as a center for innovative research through a collaborative effort

— 36 —

Center for High-Risk Pregnancies At the Center for High-Risk Pregnancies, University of Tennessee Regional One Physicians (UTROP) care for women with various complications in pregnancy that may occur before conception, during pregnancy, during delivery or in the postpartum period. Since 2010, Maternal-Fetal Medicine specialists have been working closely with a multidisciplinary team to carefully monitor patients and to provide diagnoses, testing and treatment to women and their infants with comorbidities.

Team members take great care to answer any of their patientsâ&#x20AC;&#x2122; questions, and to provide compassionate, expert care to women and their families. The centerâ&#x20AC;&#x2122;s specialists are up to date on the latest research and treatments, often engaging in research of their own to further societyâ&#x20AC;&#x2122;s overall medical knowledge. They also take pride in providing a warm and welcoming environment for patients and their infants. Over 5,000 visits and ultrasounds per year are performed at this facility.

Ultrasound Our obstetrical ultrasound team performs approximately 15,000 ultrasounds per year. The ultrasound clinics are staffed by six Maternal Fetal Medicine specialists, ten ultrasonographers, three MFM fellows, and one ultrasound Fellow. The team uses state of the art ultrasound equipment.

The creation of the ultrasound fellowship represents one of the highlights in education in recent years. We have now graduated our first two ultrasound Fellows. At the completion of the fellowship, our fellows have a solid foundation of knowledge and outstanding skills in prenatal ultrasound.

At the Regional One Outpatient Center, UTHSC physicians perform more than 7,000 ultrasounds per year. This number continues to increase, as the ultrasound team led by Dr. Mauro Schenone, MD, FACOG, works on improving operational processes that have made this team highly effective, while maintaining quality and safety of care. The hiring of enthusiastic and skilled sonographers has lead the team to a new era in which morale, work ethic, and team spirit are high. From a wait time of weeks, from ultrasound request to appointment, the team has gone as far as to achieve same day appointments. This transformation has made the experience of our patients, and those referred from many practices in the region, a more timely and pleasant one.

We have also welcomed international visiting scholars interested in learning about our unit; the demand for such visits has increased over the years. Our ultrasound team has participated in high-impact research studies and publications, including international multicenter studies; among these, the development of a non-invasive method to assess fetal lung maturity (PATET). The team has also contributed to the publication of a novel quality improvement process to reduce the proportion of reported findings unsupported by stored images (PORFUSI). Dr. Schenoneâ&#x20AC;&#x2122;s team performs consultations for women with at-risk pregnancies, comprehensive ultrasound, 3-D and 4-D ultrasound, fetal echocardiography, Doppler ultrasonography, chorionic villus sampling, and amniocentesis, as well as other procedures.

Regarding education, our team has designed a well-structured curriculum for resident ultrasound education involving theory and practice sessions, evaluation, and feedback. The team is currently working on restructuring ultrasound medical student education with similar concepts. In addition, ongoing efforts are aimed at incorporating ultrasound simulation.

The ultrasound crew continues to strive for excellence, innovation, and reliability in patient care, education, and research. It is now positioned as one of the most productive and successful units in our system. â&#x20AC;&#x201D; 38 â&#x20AC;&#x201D;

The Le Bonheur Fetal Center Expectant mothers sometimes have special needs during pregnancy and the specialists at Le Bonheur Children’s Fetal Center provide maternal-fetal health services for those high-risk pregnancy patients. The Fetal Center is the only center in the area that offers a complete range of services from prenatal diagnosis through fetal interventions. Regional One Health’s prenatal diagnosis team and the CHRP work together with the Fetal Center to ensure that each patient receives the best care available. It is also one of less than 30 centers in the country focused entirely on babies diagnosed in utero with a congenital anomaly. The Fetal Center has helped over 200 families annually since opening in 2009. When a patient comes from another state or drives for hours, the center provides a “one-stop shop.” A patient can have all necessary tests for diagnosis completed in one day (ultrasound, fetal echocardiogram, amniocentesis, and MRI). The patient and her family meet with all of the doctors involved in her care, who answer any and all of her questions and discuss the prognosis of the case. The Team Approach The medical team at the Fetal Center includes board-certified maternal-fetal medicine specialists, pediatric specialists, and support staff, who help patients plan for delivery and the baby’s care after birth. The team helps patients understand the baby’s condition at every stage. The team partners with families and primary obstetricians to choose the best courses of treatment, both before and after the child’s birth. Preparing Siblings Often, patients already have children who need help learning about their new sibling’s special needs. Le Bonheur’s child life specialists are available to help. Using age-appropriate resources, child life specialists can help siblings feel like a part of the process. Education Care Plans for Expectant Mothers An individual plan is developed for each mother that will ensure her educational needs are met before the baby’s delivery. The plan focuses on topics including the delivery plan, care of the infant after delivery, breastfeeding, and postpartum support.

Parent Mentors If a patient would like to talk with a family who has been through a similar experience at the Fetal Center, one is available through the Parent Mentor Program. The Fetal Center’s parent mentor can offer support, guidance, and discuss her experience with the Fetal Center. Palliative Care Team The Palliative Care Team is available to speak with families about any ethical issues they may be facing. They provide parents and families the opportunity to voice concerns and desires regarding the care of their baby after birth. Having a high-risk pregnancy is stressful, and Le Bonheur’s Palliative Care Team is available to provide parents with extended comfort and support. Fetal Center Reunion This event offers families a time to reconnect with the team that helped care for them during the birth and delivery of their babies. Fetal Center families can also come together and share their experiences, and make new friends.

In-Utero Intervention Team The Fetal Therapy Program at UTHSC is life changing for many families. The team performs procedures that can mean the difference between life and death for fetuses dealing with rare issues.

Fetal interventions and procedures include:

As a referral center that serves a large area, our team is exposed to a greater number of cases than many other centers in the country.

• Fetoscopy

The fetal therapy team uses the scientific evidence available to offer procedures that may potentially be life savers. Our team distinguishes itself from others in the experience and skills that our members possess. Such skills and training allow us to go beyond the routine in maternal-fetal medicine, to offer procedures and therapies that are available in only very few centers in the country.

• Cordocentesis

• Laser for Twin-to-Twin Transfusion Syndrome • Treatment for TRAP • Placement of shunts • Fetal transfusion • Vesciocentesis • Pleurocentesis • Amniocentesis • Chorionic Villus sampling • Amniotic Band Syndrome intervention • EXIT procedures

— 40 —

The combined experience of our fetal therapy experts, led by Dr. Giancarlo Mari, MD, chair of the Department of Obstetrics and Gynecology, and Dr. Mauro H. Schenone, MD, director of the Division of Maternal-Fetal Medicine, adds up to hundreds of cases and many studies published in peer-reviewed scientific journals that have helped to shape fetal diagnosis and therapy as we know it today. Our team also relies on highly skilled and experienced nurses, sonographers, anesthesiologists, and surgical technologists, who are committed to assemble whenever a case present. The fetal therapy team engages regularly in simulation exercises that enhance quality and safety in patient care.

Our center emphasizes a multidisciplinary approach to fetal therapy. Consultation with several subspecialty practitioners per case is the rule rather than the exception. Such subspecialties include, but are not limited to: neonatology, pediatric surgery, neurosurgery, urology, ENT, plastic surgery, orthopedic surgery, cardiology, cardiac surgery, palliative care, radiology, ethics, and child life, among others. The Fetal Therapy Program team works with referring physicians to help them take care of their patients. Our team partners with those referring physicians as well as with the patients to provide complete care.

IUGR Clinic There are approximately 400,000 babies that are born in the United States each year who suffer from intrauterine growth restriction (IUGR) and are born with a weight at < 10th percentile. Despite more than 15,000 published papers in peer-reviewed journals, the diagnosis of IUGR is different in different areas of the world. In addition, the percentage of constitutionally and pathologically small fetuses is not known. Furthermore, the management and timing of delivery for these fetuses is also controversial.

At Regional One Health, we have a dedicated IUGR Clinic led by a group of experts in the field. Patients in this clinic are also included in research with the goal of improving the detection, management, and optimization of delivery for IUGR fetuses. When patients with IUGR are admitted to the hospital, they undergo intensive surveillance with 24-hour a day fetal monitoring.

OB Opioid Maintenance Clinic OB Special Care Clinic 1 provides coordinated prenatal care for pregnant women on maintenance therapy for opioid use. The clinic works closely with local buprenorphine and methadone providers to monitor maintenance therapy for optimal maternal and neonatal outcomes. In addition, the clinic provides neonatology consultation to discuss care and treatment of infants as needed after delivery.

Althought the University of Tennessee Health Science Center recently established the Center for Addiction Science, the clinic is involved in a research protocol to identify genetic factors that may predispose infants to Neonatal Abstinence Syndrome. The clinic is staffed by the Division of Maternal-Fetal Medicine with a dedicated clinic nurse, a research coordinator, and dedicated research nurse. The clinic is directed by Dr. Norm Meyer.

â&#x20AC;&#x201D; 43 â&#x20AC;&#x201D;

Perinatal Center Tennesseeâ&#x20AC;&#x2122;s Perinatal Regionalization Program was established by law in 1974 and includes both obstetric and neonatal components. The goal of the program is to improve perinatal outcomes in the state by providing quality care to every mother and newborn. There are five perinatal regions in Tennessee: Northeast, East, Southeast, Middle, and West. Each region is comprised of a group of contiguous counties and contains one Regional Perinatal Center, which has been designated by the Commissioner of the Tennessee Department of Health. Funding for the Regional Perinatal Centers is provided through the Tennessee Bureau of TennCare. The Perinatal Regionalization Program is administered by the Tennessee Department of Health, Division of Family Health and Wellness. The center serving the 21 counties in West Tennessee is located in Memphis and housed at The Regional Medical Center at Regional One Health (ROH). The obstetric director of the West Tennessee Perinatal Center is Dr. Giancarlo Mari. Dr. Ramasubbareddy Dhanireddy serves as the newborn director. Each of Tennesseeâ&#x20AC;&#x2122;s Regional Perinatal Centers is required to provide the following services:

1. C onsultation and referral of high-risk obstetric and neonatal patients. This may include a variety of activities, such as telephone consultation or outpatient care by a perinatologist (maternalfetal medicine specialist) for ultrasound, prenatal diagnosis, or care of chronic illnesses (for example, diabetes and chronic hypertension) during pregnancy. This service component also includes the transfer of high-risk obstetric and neonatal patients from outlying hospitals in the region to ROH for care 2. P rofessional education for health care providers in the region in regard to low and high-risk obstetric and neonatal care 3. Maternal-fetal and neonatal transport 4. Post-neonatal follow-up 5. S ite visits to hospitals and birthing centers in the region, upon request 6. Data collection. West Tennessee Regional Perinatal Center staff members have been striving for more than 40 years to improve outcomes for mothers and babies in our state. We plan to continue providing excellent care to health care providers and families for many years to come.

Reproductive Genetics Dr. Owen Phillips is a board-certified medical geneticist and a board-certified obstetrician gynecologist, the only such dual-boarded physician in the Mid-South. Her practice of reproductive genetics concentrates on the counseling and care of patients who are at risk for having a child with genetic disease.

and counseling couples and individuals on their risks. She also specializes in offering screening and prenatal testing (when appropriate), discussion of results and assisting couples in pregnancy-management decisions. She is skilled at amniocentesis and chorionic villus sampling and works closely with the ultrasonography team and maternal fetal medicine specialists to provide a comprehensive evaluation.

The field of genetics is rapidly expanding and becoming more complicated. Dr. Phillips specializes in taking an in-depth family history, researching

â&#x20AC;&#x201D; 45 â&#x20AC;&#x201D;

Center for Reproductive Endocrinology and Infertility and used once the cancer is in remission, and the patient is ready to have a family. The program offers the most current option of ovarian tissue cryopreservation, in addition to traditional egg and sperm cryopreservation, and serves Le Bonheur Children’s Hospital and other hospitals in the Memphis area. Planned, or “social” cryopreservation of oocytes has recently gained attention. This is for women who want to retain their ability to have children in the future, to protect themselves against future infertility due to reproductive aging or other unforeseen developments. These may include disease, primary ovarian insufficiency, traumatic injury, or planned female-to-male gender transition. ROH Reproductive Medicine offers expertise and competitive financial programs to their patients.

Couples who have trouble getting pregnant sometimes feel as if they are the only ones with the problem. In reality, more than seven million Americans — both men and women — may experience infertility. The Reproductive Endocrinology and Infertility (REI) Division at UTHSC offers many options to help couples struggling with infertility to achieve their dreams of parenthood. The REI Division provides comprehensive infertility testing and a treatment program for both men and women at ROH Reproductive Medicine. The center combines cutting-edge science and state-of-theart equipment to diagnose and treat infertility. Along with providing a comprehensive approach to treating infertility, the center boasts an imaging center, equipped with both 3-D and 4-D ultrasound capabilities; procedure rooms; and andrology and embryology laboratories. These laboratories are registered with the Food and Drug Administration and the Society for Assisted Reproduction Technologies (SART), and licensed by the state of Tennessee and by Clinical Laboratory Improvement Amendments (CLIA).

To cover some of the costs involved with these programs, the Center for Reproductive Medicine partners with Advanced Reproductive Care, Inc., an organization that specializes in financing assisted reproductive procedures at qualified universityaffiliated fertility clinics in the United States. The center at UTHSC is the only Mid-South practice that offers this financing program, and is the only member of the organization in the state of Tennessee. Along with state-of-the-art equipment and facilities, the REI Division boasts several of the Mid-South’s top specialists. The In Vitro Fertilization (IVF) team provides success rates that are among the highest in the country. The center’s slogan

The center also provides a comprehensive fertility preservation program for men and women. Cancer patients, who must undergo toxic chemotherapy and radiation treatments, are prime candidates for fertility preservation. Eggs, sperm and tissue can be obtained prior to cancer treatment, frozen, — 46 —

is “hope grows, miracles happen,” a testament to division members’ constant commitment to patients.

Adolescent Medicine

Claudette Shephard, MD, is an expert in pediatric and adolescent gynecology. She has more than 20 years of experience, and is also the residency director for the department of OB/GYN.

• Female adolescent medicine and endocrinology

Laura Detti, MD, is a double board-certified OB/ GYN and REI specialist, and is the director of the IVF and Fertility Preservation programs at ROH Reproductive Medicine. She is a 3-D and 4-D, AIUMaccredited, ultrasound expert with more than 15 years of experience, and also cares for pediatric and adolescent cancer survivors at St. Jude Children’s Research Hospital. She has published extensively on topics such as optimization of IVF, fertility preservation, and the surgical treatment of uterine abnormalities; and has provided new insights into the understanding of Müllerian anomalies. She is frequently invited to present her research and clinical expertise at national and international conferences. More recently, she has been the chair of the ultrasound meeting organized by the Cleveland Clinic and has chaired the ultrasound section at the American Society of Reproductive Medicine (ASRM). Approximately 8,000 doctors from around the globe attend the yearly ASRM meeting.

•O n-site procedure room for oocyte retrieval/ embryo transfer

• Female pre- and post-pubertal conditions

Assisted Reproduction Program

• Oocyte cryopreservation • Egg donation • Intracytoplasmic sperm injection (ICSI) • Assisted hatching • Blastocyst culture • Embryo biopsy and cryopreservation •P reimplantation genetic testing (for screening and diagnosis) •A dvantageous financial program through ARC fertility (arcfertility.com) Full Service Andrology Laboratory • I ntrauterine insemination (IUI) using husband or donor sperm • Sperm wash •S emen analysis with kruger strict criteria morphology

SERVICES OFFERED: Fertility Consultations • Female infertility

Fertility Preservation Program

• Male infertility

• Sperm cryopreservation

• Fertility before and after cancer treatments

• Ovarian Tissue cryopreservation

• Genetic counseling

• Oocyte cryopreservation

• Social fertility preservation

AIUM-Accredited Ultrasound Service

Fertility-Related Diagnosis and Management

• 3D and 4D gynecologic ultrasound

• Amenorrhea

• Sonohysterography

• Abnormal uterine bleeding/abnormal periods

• Tubal patency detection

• Uterine malformations

• Follicular monitoring

• Uterine fibroids

• Early pregnancy ultrasound

• Ovarian pathology • Endocrine dysfunctions

Advanced Minimally Invasive Surgery Program

• Ovulatory dysfunction

• Robotic surgery

• Polycystic ovary syndrome

• Hysteroscopy

• Recurrent pregnancy loss

• Laparoscopy

• Pelvic adhesions/pain

• Tubal reversal — 47 —

Certified Nurse Midwives Regional One Health supports expectant mothers looking for a non-traditional birth experience. We are the only hospital in Memphis that staffs Certified Nurse Midwives as part of our OB/GYN team. Our Certified Nurse Midwives encourage women to be active advocates in their prenatal, birth, and postnatal care. They are available to provide personalized, patient directed support during this special time. Regional One Health provides the opportunity for expectant mothers to experience the lowintervention care of a midwife, while having access to the emergency services and technological expertise a hospital delivery ensures. Our midwives follow evidence-based care guidelines. They work closely with our generalist and MFM obstetricians, as well as ROH specialist teams to deliver quality care; and partner with patients to evaluate interventions as necessary.

In addition to delivering infants in the hospital, our midwife team sees patients at several Regional One outpatient care sites Monday through Friday for low-risk obstetrics and well-woman primary care. Because they are licensed as advanced practice nurses and certified health care professionals, our Certified Nurse Midwives provide a wide range of services to women of reproductive age, including: • Preconception care •C omprehensive prenatal care, including optional group prenatal care • Annual examinations • Gynecological examinations • Birth control counseling and management • Breastfeeding education and support •L abor support and management of vaginal deliveries • Postpartum care The Regional One Health team of midwives staffs the hospital 24/7, so they are always available for your needs. Regional One Health’s certified Nurse Midwives are masters-prepared nurses with Registered Nurse (RN) and Advanced Practice Registered Nurses (APRN) licensures. They also are certified through the American Midwifery Board.

Gynecologic Oncology Division The Division of Gynecologic Oncology is actively involved in all modalities of care for more than 1,000 new patients annually. Patients who see members of the division have access to the most advanced cancer treatments available anywhere. A multidisciplinary team provides a full range of diagnostic and treatment services. Primarily, the gynecologic oncology team sees patients at the West Cancer Center, but they also admit patients from hospitals all over Shelby County.

â&#x20AC;&#x201D; 49 â&#x20AC;&#x201D;

Minimally Invasive Gynecologic Surgery Center Within the Department of OB/GYN at UTHSC, we are pleased and excited to have the Division of Minimally Invasive Gynecologic Surgery (MIGS). The division is directed by A. Ben Abdu, MD, and is committed to the highest standards of care in Advanced Laparoscopy, Robotics, and Urogynecology. The goal of the UTHSC MIGS Program is in line with the AAGL mission statement, â&#x20AC;&#x153;To advance the use of minimally invasive gynecologic surgery worldwide for the benefit and safety of the patients who our surgeons treat.â&#x20AC;?

Residents and Fellows have the unique opportunity to learn the most up to date minimally invasive surgery techniques (vaginal, laparoscopic, and robotic) with procedures such as excision of endometriosis, appendectomy, myomectomy, tubal re-anastomosis surgery, hysterectomy, and pelvic organ prolapse surgery.

Urogynecology Division Dr. S. Gregory Portera, MD has been an essential part of the training of residents in Female Pelvic Medicine and Reconstructive Surgery. A 1996 graduate of our OB/GYN residency program, he then completed subspecialty fellowship training in Urogynecology and Reconstructive Pelvic Surgery in our department. Since 2004, he has been

responsible for the education of Chief Residents in Female Pelvic Medicine & Reconstructive Surgery. One of the favorite rotations of the year, residents emerge from the experience with a better understanding of the pelvic floor and enhanced skill in vaginal hysterectomies, anterior/posterior colporrhaphy and sling procedures.

â&#x20AC;&#x201D; 51 â&#x20AC;&#x201D;

Pediatric and Adolesent Gynecology Clinic Pediatric and Adolescent Gynecology at UTHSC provides comprehensive, dedicated, age-appropriate care for newborns through adolescent females. The reproductive health needs of prepubescent and adolescent females differ in many ways from adult women, and close attention to these needs is key to developing trust with younger patients. Under the direction of Claudette Shephard, MD, the only fellowship-trained Adolescent Gynecologist in the region, the Pediatric and Adolescent Clinic provides comprehensive gynecologic services to girls and young women in Memphis. Dr. Shephard and her staff are uniquely qualified to evaluate the reproductive needs of girls and teens, and they thoughtfully approach the medical and surgical management of problems that may have profound consequences on sexual development and future fertility.

More than 100 different physicians and groups around the region refer patients to Dr. Shephard’s care at UTHSC. The referral network for the clinic covers West Tennessee, Northern Mississippi, Eastern Arkansas, and the bootheel of Missouri. The majority of patients seen here are given medical care in an ambulatory setting, with more than 2,000 patients scheduled each year. The issues that Dr. Shephard and her team treat include (but are not limited to): • abnormalities of development • vaginal bleeding in prepubertal female • vaginal discharge • sexual abuse • breast development • vulvar abnormalities • menstrual disorders • sexually transmitted diseases • risky sexual behavior assessment and counseling The goals of the Pediatric and Adolescent Gynecology service at UTHSC are to provide anticipatory guidance, identify issues, help patients feel comfortable with their bodies, educate patients and their parents, and to empower young women to take care of themselves.

Menopausal Clinic According to reports, over 2 million women enter menopause each year, and current estimates suggest 41 million women are currently at the age of menopause (~ 51 years) in the U.S. By 2020, it is projected the number of U.S. women over the age of 51 will be greater than 50 million (NAMS, 2014). This period in a women’s reproductive life provides a unique opportunity for counseling and often management of symptoms that occur with hormone changes. Having a specialized clinic with clinicians having specialized education to focus on developing an individualized menopausal plan of care for the woman can offer new and valued health care services that have not been well met in the community.

American Menopause Society (NAMS) Certified Menopause Practitioners (NCMP). Founded in 1989, NAMS is North America’s leading nonprofit organization dedicated to improving health and quality of life through an understanding of menopause. Holders of the NCMP certification have demonstrated special interest and competency in the field of menopause. That includes physicians, physician assistants, nurse practitioners, nurse midwives and pharmacists. Dr. Pallavi Khanna, MD, is an academic specialist in Obstetrics and Gynecology. Dr. Diane Todd Pace, Ph.D., APRN, FNP-BC, NCMP, FAAN, is an associate professor and the director of special academic programs at the University of Tennessee Health Science Center College of Nursing. She is the first nurse practitioner to serve as president of the North American Menopause Society, and has had her NCMP certification since 2001.

Our menopause clinic focuses on gynecological care of women at midlife and postmenopausal state. We provide focused care in general gynecology for women over 40, abnormal uterine bleeding, behavioral health related to perimenopause, decreased libido in menopausal transition, genitourinary syndrome of menopause, hot flushes and related symptoms. Dr. Pallavi Khanna and Dr. Diane Pace, are both North

Both Drs. Khanna and Pace have collaborated in developing a focused clinical environment, in our community that provides specialized care for women at this phase of their reproductive life.

— 53 —

Center for HPV and Dysplasia The Center for Disease Control estimates that nearly 80 million people, about one in four, are currently infected with human papillomavirus in the United States. Approximately 31,500 human papillomavirus (HPV) associated cancers are diagnosed across the U.S. each year. The clinicians at the Center for HPV and Dysplasia (CHAD), led by Wendy Likes, PhD, DNSc, board certified Advanced Practice Registered Nurse, and Marina Santa CruzTerrazas, MD, are dedicated to working with men and women in the Memphis area to prevent such cancers. The CHAD offers treatment for men and women at risk for or identified with dysplasia, including cervical, anal, and vulvar dysplasia. Our clinicians

are dedicated to the prevention of cancers related to HPV through education, screening, evaluation, and treatment. The CHAD possesses stringent research protocols, state-of-the-art colposcopy/high resolution anoscopy and imaging equipment and educational support for those affected by and seeking to prevent HPV. CHAD clinicians assess each patient’s risk factors individually, ensuring that the best care be given on a case-by-case basis. The CHAD also has access to UTHSC’s multidisciplinary team, to handle special circumstances without having to refer a patient to an outside center. Approximately 100 visits per year are performed at this facility.

— 54 —

Biostatistics and Research Our Obstetrics and Gynecology/Maternal Fetal Medicine doctors are world-renowned physicianscientists who lecture nationally and internationally on a range of topics. Through research, they have developed procedures that have changed the standard of care in prenatal diagnosis and intervention in the world. Our MFM physicians have pioneered treatments for twin-to-twin transfusion syndrome (TTTS) since 1987, and have developed a non-invasive method to diagnose fetal anemia with ultrasound that has become the standard of care for the diagnosis of fetal anemia globally. The REI Division has recently developed new guidelines for the management of intrauterine septum. Our OB/GYN and MFM faculty and Fellows are engaged in a number of basic science and clinical research projects. They have established collaborative relationships with Division of Biostatistics faculty and staff regarding methodological issues such as study design, sample size and power, and analytical methods. Their research projects include animal studies of preeclampsia, observational studies looking at the association between ultrasound measures and maternal/child outcomes, prediction of miscarriage, a big data structural equation analysis of obesity’s impact on risk of cesarean delivery, genetic studies involving placenta samples, and randomized studies such as testing monitoring vs. non-monitoring of obese pregnant women on maternal/child

outcomes. In addition, the MFM team is involved in a NIH multicenter study for the best treatment of chronic hypertension in pregnancy. Faculty members are active sponsors and mentors in resident and fellow research projects. They provide guidance in regulatory submission, study design, and planning and implementation. Many of these projects are presented at regional, national, and international meetings and are ultimately published. Ongoing Research • Preeclampsia Model • IUGR • BMI • Multiple Gestations • Substance Abuse • Chronic Hypertension • Tissue Bank • Preterm Delivery • Superimposed Preeclampsia • Non-Invasive Diagnosis of Fetal Lung Maturity • Placenta • Prevention of BroncoPulmonary Dysplasia • Doppler in Preeclampsia • Alcohol and Pregnancy • PROM

St. Jude Children’s Research Hospital For more than 20 years, the Department of Obstetrics and Gynecology has worked with St. Jude Children’s Research Hospital to help cancer survivors with gynecologic and reproductive issues related to their cancer treatments. UTHSC providers — Laura Detti, MD, and Owen Phillips, MD — see patients at St. Jude for gynecological care, from

adolescence until well after cancer has been cured. Treatments range from routine gynecologic care to managing disorders related to cancer therapy, ovarian insufficiency, HIV and hormone therapy. Dr. Danielle Tate is the director of the HIV clinic and has led several projects and grants with the Infectious Disease team at St. Jude.

— 56 —

Regional One Health Regional One Health is deeply rooted in the MidSouth community with a unique commitment to serving all citizens. It has the expertise, research orientation, and commitment to innovation to play a unique role in advancing the quality of health care in Tennessee. Regional One Health, formerly John Gaston Hospital and the Regional Medical Center, is the oldest hospital in Tennessee, with a history of serving the region’s sickest patients. Its experience with some of the most challenging health crises a patient can face makes it uniquely qualified to provide a high quality of care. Regional One Health provides services to residents from all backgrounds in a 150-mile radius from its main campus. All locations are meant to serve patients where it‘s convenient for them, from East Memphis to Harbor Town. Through the foundation, Regional One Health brings hope and healing to

thousands of patients in the community by helping to purchase state-of-the-art medical technology, provide advanced medical training for its caregivers, and initiate programs to combat various community health issues. Regional One Health’s academic partnership with the UT Health Science Center includes the physician group, UT Regional One Physicians, the largest teaching physician group in the Mid-South, creating opportunities for improved outcomes through research and innovation. Regional One Health’s new East Campus is the first of its kind in the region to embrace the concept of a “medical neighborhood” where patients can seamlessly transition between doctor visits, imaging services, physical therapy, and more. More than half the doctors in Tennessee receive all or part of their training at Regional One Health.

OB/GYN Faculty and Fellows A. Ben Abdu, MD Assistant Professor 901.448.2531 aabdu@uthsc.edu MIGS/UroGynecology Division

Jennifer Barr, MD MFM Fellow 901.448.1053 jbarr@uthsc.edu MFM Division

Pedro Argoti, MD Assistant Professor 901.448.5393 pargotit@uthsc.edu OB/GYN Generalist Division

Kerri Brackney, MD Assistant Professor 901.448.7286 kbrackne@uthsc.edu OB/GYN Generalist Division

Michael Aziz, MD MFM Fellow 901.448.1053 maziz5@uthsc.edu MFM Division

Laura Detti, MD Professor 901.448.5373 ldetti@uthsc.edu REI Division

Roberto Levi-D’Ancona, MD Associate Professor 901.448.5859 leviro@uthsc.edu OB/GYN Generalist Division

Laura Grese-Willingham, MD Instructor 901.448.4795 lgrese@uthsc.edu OB/GYN Generalist Division

— 58 —

Molly Houser, MD Assistant Professor 901.448.7286 mhouser1@uthsc.edu MFM Division

Linda Moses, MD Assistant Professor 901.448.7286 lmosessi@uthsc.edu OB/GYN Generalist Division

Pallavi Khanna, MD Assistant Professor 901.448.2531 pkhanna1@uthsc.edu OB/GYN Generalist Division

Owen Phillips, MD Professor 901.448.7286 ophillip@uthsc.edu OB/GYN Generalist Division

Giancarlo Mari, MD, MBA Professor and Chair 901.448.2531 gmari@uthsc.edu MFM Division

Ramona Phinehas, MD Instructor 901.448.5393 rphineha@uthsc.edu OB/GYN Generalist Division

Norm Meyer, MD, PhD Professor 901.448.7286 nmeyer@uthsc.edu MFM Division

Ashekia Pinckney, MD Instructor 901.448.5393 apinckne@uthsc.edu OB/GYN Generalist Division

— 59 —

OB/GYN Faculty and Fellows (cont.) Greg Portera, MD Assistant Professor 901.227.9610 sportera@uthsc.edu Uro-Gynecology Division

Fernand Samson, MD MFM Fellow 901.448.1053 fsamson@uthsc.edu MFM Division

Tiffany Redfern, MD Gyn/Oncology Fellow 901.683.0055 tredfern@uthsc.edu Gynecologic Oncology Division

Marina Santa-Cruz Terrazas, MD Instructor 901.448.5393 msantacru@uthsc.edu OB/GYN Generalist Division

Mark Reed, MD Assistant Professor 901.683.0055 mreed@westclinic.com Gynecologic Oncology Division

Mauro Schenone, MD Associate Professor 901.448.7286 mschenon@uthsc.edu MFM Division

â&#x20AC;&#x201D; 60 â&#x20AC;&#x201D;

Claudette Shephard, MD Associate Professor 901.448.5393 cshephard@uthsc.edu OB/GYN Generalist Division

Todd Tillmanns, MD Professor 901.683.0055 ttillmanns@westclinic.com Gynecologic Oncology Division

Linda Smiley, MD Assistant Professor 901.683.0055 lsmiley@westclinic.com Gynecologic Oncology Division

Michael Ulm, MD Gyn/Oncology Fellow 901.683.0055 mulm@uthsc.edu Gynecologic Oncology Division

Danielle Tate, MD Assistant Professor 901.448.7286 dtate5@uthsc.edu MFM Division

â&#x20AC;&#x201D; 61 â&#x20AC;&#x201D;

OB/GYN Faculty and Fellows (cont.) OB/GYN ADJUNCT FACULTY Wendy Likes, PhD, DNSc Dean, College of Nursing 901.448.6135 wlikes@uthsc.edu

Nina Sublette, PhD, APRN-BC 901.448.2696 nsublett@uthsc.edu

Diane Todd-Pace, PhD, APRN 901.448.2794 dpace@uthsc.edu

— 62 —

OB/GYN NURSE PRACTITIONERS Renee Abdu, WHNP-BC 901.515.3800 cabdu@ regionalonehealth.org MFM Division

Ebony Smith, WHNP-BC 901.515.3800 emsmith@ut-rop.org MFM Division

OB/GYN MIDWIVES Davin Johnson, CNMW 901.515.5500 dpjohnson@ regionalonehealth.org OB/GYN Generalist Division

Breia Loft, CNMW 901.515.5500 bloft@regionalonehealth.org OB/GYN Generalist Division

Meghan Madea, CNMW 901.515.5500 mmadea@ regionalonehealth.org OB/GYN Generalist Division

— 63 —

Edna Tucker, CNMW 901.515.5500 emtucker@ regionalonehealth.org OB/GYN Generalist Division

Amanda Williams, CNMW 901.515.5500 amwilliams@ regionalonehealth.org OB/GYN Generalist Division

2016-18 Publications and Presentations

8. Aziz MM. Accepted to the American Institute of Ultrasound in Medicine (AIUM) Annual Convention; 2018 March 24; New York, NY.

Pedro Argoti

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Vilchez G, Argoti P. Mean Platelet Volume (MPV) vs. Current Laboratory Markers in Preeclampsia: Is MPV a better biomarker? Journal of Obstetrics and Gynaecology Research. 2017 Jun; 43(6):982-990.

9. Aziz MM. Presented at the New Jersey Maternal-Fetal Medicine Society Annual Research Award Dinner; 2016 May 21; Monroe Township, NJ. (Podium, Awarded 3rd Place Prize) 10. Aziz MM, Kulkarni A, Tunde-Agbede O, Benito C, Oyelese Y. Are patients with threatened preterm labor more dehydrated than women without it? Presented at the 36th Annual Meeting of the Society for Maternal Fetal Medicine, Atlanta, GA February 5th, 2016 (Poster)

2. Smith, JA, Donepudi R, Argoti P, Giezentanner AL, Jain R, Boring N, Garcia E, Moise KJ. Exploring the pharmacokinetic profile of remifentanil in mid-trimester gestations undergoing fetal intervention procedures. Front Pharmacol. 2017 Jan 24; 8:11.

INVITED LECTURES: 1. Aziz MM. (2016 October) Syphilis and HIV in Pregnancy”. Morristown Medical Center Pediatrics and Perinatology Working Group.

3. Vilchez G, Hoyos LR, Leon-Peters J, Lagos M, Argoti P. Differences in clinical presentation and pregnancy outcomes in antepartum preeclampsia and new-onset postpartum preeclampsia: Are these the same disorder? Obstet Gynecol Sci. 2016 Nov; 59(6):434-443

2. Aziz MM. (2016 October) Hemostatic Agents and their use in Obstetrics”. Morristown Medical Center Department of Obstetrics & Gynecology Journal Club.

Michael Aziz

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Kulkarni A, Powell J, Aziz MM, Shah L, Benito CW, Oyelese Y. Vasa Previa: Prenatal Diagnosis and Outcomes- 35 Cases From a Single Maternal-Fetal Medicine Practice. J Ultrasound Med. 2018 Apr.; 37(4):1017-1024.

3. Aziz MM. (2017 January) Prenatal versus Postnatal Myelomeningocele Repair”. Morristown Medical Center Pediatrics and Perinatology Working Group; 2017 January. 4. Aziz MM. Thyroid Disease in Pregnancy”. University of TN Health Science Center Department of Obstetrics & Gynecology Resident Lecture.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Duncan J, Aziz MM, Dorsett K, Mari G, Schenone M. Fetal pulmonary artery acceleration/ejection time predicts respiratory complications in PPROM. Accepted to the American Institute of Ultrasound in Medicine (AIUM) Annual Convention; 2018 March 24; New York, NY.

5. Aziz MM. (2017 October) Preterm birth- Problem and Prevention”. Memphis Medical Society Case Management Conference. 6. Aziz MM. (2017 October) Management of Physiologic and Abnormal Labor”. University of TN Health Science Center

2. Aziz MM, Graham B, Bursac Z, Goedecke T, Dhanireddy R, Mari G, Is Cesarean Delivery an Independent Predictor of Survival in Neonates Who Weigh Fewer Than Five Hundred Grams? Accepted to the 65th Annual Scientific Meeting of the Society for Reproductive Investigation; 2018 March 6-10; San Diego, CA.

Jennifer Barr

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Barr, J.J., Macias, M., & Antonio, C. Promoting active participation in antenatal support (PAPAS): development of a novel tool for paternal education in pregnancy. Journal of Perinatal Education. 2017 Feb; Pub Status: Submitted.

3. Aziz MM, Graham B, Bursac Z, Goedecke T, Dhanireddy R, Mari G. Is maternal magnesium sulfate administration prior to delivery an independent predictor of survival in neonates who weigh fewer than five hundred grams? Accepted to the 38th Annual Meeting of the Society for Maternal Fetal Medicine; 2018 February 5; Dallas, TX.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Barr, J.J., Lee, J.Y. (2017). First trimester echocardiographicfindings in women with chronic hypertension and superimposed preeclampsia Poster presented at: American Institute of Ultrasound in Medicine; Lake Buena Vista, FL.

4. Aziz MM, Kulkarni A, Shah L, Lashley S, Oyelese Y. Physiologic proteinuria in labor and postpartum: The results of the Postpartum Proteinuria Trial (PoPPy).

AWARDS: 1. Barr, J. J. AIUM Convention Second Place E-poster (2017)

5. Aziz MM. Presented at the 1st Annual UTHSC Fellows’ Research Day, Memphis, TN November 7th 2017 (Poster)

2. Barr, J. J. Second Place Frank T. Peak Essay Contest (2017)

6. Aziz MM. Accepted to the 65th Annual Scientific Meeting of the Society for Reproductive Investigation; 2018 March 6-10; San Diego, CA.

Zoran Bursac

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Narcisse MR, Felix H, Long CR, Hudson T, Payakachat N, Bursac Z, Mcelfish PA. Frequency and Predictors of Health Services Use by Native Hawaiians and Pacific Islanders: Evidence from the U.S. National Health Interview Survey. BMC Health Services Research: in press.

7. Aziz MM, Lizarraga L, Kulkarni A, Benito C, Netta D. What is the Optimal Gestational Age to Screen for Fetal Growth Restriction in Patients with Low Pregnancy Associated Plasma Protein-A: A Retrospective Cohort Study.

— 64 —

2. Bursac Z, Klesges RC, Little MA, Linde B, Popova L, Talcott GW. The Comparative Effectiveness of Two Brief Tobacco Interventions in the U.S. Air Force: Perceived Harm and Intentions to Use Tobacco Products. Tobacco Induced Diseases: in press.

14. Salgado Garcia FI, Derefinko KJ, Bursac Z, Hand S, Klesges RC. Planning a Change Easily (PACE): A Randomized Controlled Trial of Smokers Who are Not Ready to Quit. Contemporary Clinical Trials. 2018; 68: 14-22. 15. McElfish PA, Long C, Payakachat N, Felix H, Bursac Z, Rowland B, Hudson T, Narcisse MR. Cost-Related Nonadherence to Medication Treatment Plans: Native Hawaiian and Pacific Islander National Health Interview Survey, 2014. Medical Care. 2018; 56(4): 341-349.

3. Preston M, Mays GP, Bursac Z, Thomas BR, Laryea J, Tilford M, Odlum M, Smith SA, Henry-Tillman RS. Insurance Coverage Mandates: Impact of Physician Utilization on Moderating Colorectal Cancer Screening Rates. The American Journal of Surgery: in press.

16. Derefinko KJ, Hallsell TA, Isaacs MB, Salgado Garcia FI, Colvin LW, Bursac Z, McDevitt-Murphy ME, Murphy JG, Little MA, Talcott WG, Klesges RC. Substance Use and Psychological Distress Before and After the Military to Civilian Transition. Military Medicine: in press.

4. Sanders JT, Hastings MC, Moldoveanu Z, Novak J, Bursac Z, Bush AJ, Wyatt RJ. Serum Galactose-deficient IgA1 in Children: Time Trends in IgA Nephropathy and Control Populations. International Journal of Nephrology: in press. 5. Derefinko KJ, Linde BD, Klesges RC, Puentes L, Boothe T, Leroy K, Little MA, Colvin L, Pasker C, Murphy JG, McDevittMurphy ME, Bursac Z, Ebbert JO, Brooks I, Waters T, Talcott WG. Dissemination of the Brief Alcohol Intervention in the United States Air Force: Study Rationale, Design and Methods. Military Behavioral Health: in press.

17. Hastings MC, Bursac Z, Julian BA, Villa Baca E, Featherstone J, Woodford SA, Bailey L, Wyatt RJ. Life Expectancy for Patients from the Southeastern US with IgA Nephropathy. Kidney International Reports. 2017; 3(1):99-104. 18. Christensen ML, Franklin BE, Pahde E, Bursac Z, Davis RL, Reed MD, Mattison D. Leveraging Electronic Health Data to Evaluate Pediatric Medication Use and Health Outcomes. Journal of Pharmacovigilance and Pharmacotherapeutics. 2017; 1(1):1-9.

6. Horwitz-Willis N, Phillips MM, Ryan K, Bursac Z, Ferguson A. Examining State Habitability Laws and Their Relationship to State Characteristics. The International Journal of Housing Policy: in press.

19. Singh KP, Bursac Z, Eby WM, Tabatabai MA. Innovative Models for Analysis of Survival Data. Research Reports. 2017; 1(1):e1-e5.

7. Tobiasz AM, Duncan JR, Bursac Z, Sullivan R, Tate DL, Dopico AM, Bukiya AN, Mari G. The Effect of Prenatal Alcohol Exposure on Fetal Growth and Cardiovascular Parameter in a Baboon Model of Pregnancy. Reproductive Sciences: in press.

20. Vidal G, Bursac Z, Miranda-Carboni G, White-Means S, Starlard-Davenport A. Racial/ethnic Disparities in Survival Outcomes and Breast Tumor Subtypes among African American Women in Memphis, Tennessee. Cancer Medicine. 2017; 6(7):1776-86.

8. Preston MA, Glover-Collins K, Ross L, Porter A, Bursac Z, Woods, D, Jacqueline B, Crowell K, Laryea J, Henry-Tillman RS. Colorectal Cancer Screening in Rural and Poor-resourced Communities. American Journal of Surgery: in press.

21. Little MA, Ebbert JO, Bursac Z, Talcott GW, Colvin LW, LeRoy KM, Womack CR, Hrysko-Mullen AS, Klesges RC. Enhancing the Efficacy of a Smoking Quit Line in the Military: Study rationale, design and methods of the Freedom Quit Line. Contemporary Clinical Trials. 2017; 59:51-56.

9. Yeary KHK, Long C, Bursac Z, McElfish PA. Design of a Randomized, Controlled, Comparative-effectiveness Trial Testing A Family Model of Diabetes Self-management Education (DSME) vs. Standard DSME for United States Marshallese Islanders. Contemporary Clinical Trials Communications: in press.

22. Bondurant KL, Wheeler JG, Bursac Z, Holmes T, Tilford MJ. Comparison of Office-Based Versus Outsourced Immunization Recall Services. Clinical Pediatrics. 2017; 56(6):911-916.

10. Horwitz-Willis N, Phillips MM, Ryan KW, Bursac Z, Ferguson A. Examining the Strength of State Habitability Laws Across the US. The International Journal of Housing Policy: in press.

23. McElfish PA, Goulden PA, Rubon-Chutaro J, Laelan M, Bursac Z, Hudson JS, Warmack TS, Buron B, Smith C, Purvis R, Yeary KH, Aitaoto N, Kohler PO. Engagement Practices That Join Scientific Methods With Community Wisdom: Designing a Patient-Centered Randomized Control Trial With a Pacific Islander Community. Nursing Inquiry. 2017; 24(2).

11. Derefinko KJ, Bursac Z, Mejia MG, Milich R, Lynam DR. Effects of the Transition to College on Rural and Urban Substance Use Trends. Am J Drug and Alcohol Abuse: in press. 12. Mari G, Bursac Z, Goedecke PJ, Dhanireddy R. Factors Associated with Improvements in Mortality and Morbidity Rates of Very Low Birth Weight Infants at a Regional Perinatal Center from 2004-2015. Global Pediatric Health. 2015; 5: 1-10.

24. Little MA, Pokhrel P, Sussman S, Bursac Z, Rohrbach LA. Factors Associated with the Adoption of Tobacco Cessation Programs in Schools. Journal of Smoking Cessation. 2017; 12(1): 55-62.

13. Little MA, Klesges RC, Bursac Z, Ebbert JO, Dunkle A, Goedecke PA, Weksler B. Why Don’t Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer Survivors. Journal of Cancer Prevention. 2018; 23(1): 44-50.

25. Ebbert JO, Little MA, Klesges RC, Bursac Z, Johnson KC, Thomas F, Vander Wag MW. Step Care Treatment for Smoking Cessation. Health Education Research. 2017; 32(1):1-11.

— 65 —

Roberto Levi-D’Ancona

26. Krukowski RA, Bursac Z, Linde BD, Talcott GW, Tedford E, Klesges RC. Gestational Weight Gain Among Military Members and Dependents. Military Behavioral Health. 2016; 4(3): 293-298.

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Schenone M, Duncan J, Levi-D’Ancona R, Mari G. Doppler ultrasonography for the diagnosis and management of fetal anemia, hydrops, and fetal lung maturity. In: Fleischer’s Sonography in Obstetrics & Gynecology textbooks and teaching cases 8th ed. 2017; New York, NY. McGraw Hill Education.

27. Popova L, Linde BD, Bursac Z, Talcott WG, Modayil MV, Little MA, Ling PM, Glantz SL, Klesges RC. Testing Anti-smoking Messages for Air Force Trainees. Tobacco Control. 2016; 25(6):656-663.

ABSTRACTS (POSTERSAND ORAL PRESENTATIONS): 1. Alan H Appelbaum AH, Zuber JK, Levi-D’Ancona R, Cohen RH. Vaginal Anatomy on MRI - New Information Obtained Using Distention, Accepted for Oral Presentation, Southern Medical Association Annual Scientific Assembly; 2016 November 3-5; Chattanooga, TN.

28. Marino KA, Little MA, Bursac Z, Sullivan JL, Klesges RC, Weksler B. Operating on Patients Who Smoke: A Survey of Thoracic Surgeons in the United States. Annals of Thoracic Surgery. 2016; 102(3):911-916. 29. Little MA, Bursac Z, Derefinko KJ, Ebbert JO, Talcott GW, Hrysko-Mullen A, Klesges RC. Types of Dual and Poly Tobacco Users in the United States Military. American Journal of Epidemiology. 2016; 184(3):211-218.

INVITED LECTURES: 1. Levi-D’Ancona R. (2017 August 1-5) A practical approach to management of menopause; 31st Annual Contemporary Issues in Obstetrics and Gynecology; Sandestin, FL.

30. Derefinko KJ, Klesges RC, Bursac Z, Little MA, HryshkoMullen A, Talcott GW. Alcohol Issues Prior to Training in the United States Air Force. Addictive Behaviors. 2016; 18(58):142-48.

2. Levi-D’Ancona R. (2017 May 14-17) Ultrasound features of benign adnexal pathology XX National Congress SIEGO (Congresso Nazionale SIEGO Ostetricia e Ginecologia); Florence, Italy.

31. Little MA, Talcott GW, Bursac Z, Linde BD, Pagano LA, Messler EC, Ebbert JO, Klesges RC. Efficacy of a Brief Tobacco Intervention for Tobacco and Nicotine Containing Products in the United States Air Force. Nicotine and Tobacco Research. 2016; 18(5): 1142-9.

AWARDS: 1. Levi-D’Ancona R. APGO Excellence in Teaching Award University of Tennessee Health Science Center (2016)

Laura Daily

32. Krukowski RA, Bursac Z, Little MA, Klesges RC. The Relationship Between Body Mass Index and Postcessation Weight Gain in the Year After Quitting Smoking: A Cross Sectional Study. PLoS ONE. 2016; 11(3): 1-12. (e0151290)

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Daily LR, Boone JD, Machemehl HC, Thomas ED, McGwin G, Straughn JM, Leath CA III. Does obesity affect pathologic agreement of initial and final tumor grade of disease in endometrial cancer patients? Int J Gynecol Cancer. 2017 (In press)

33. Little MA, Klesges RC, Bursac Z, Colvin L, Ebbert J, Talcott W, Richey P. Prevalence and Correlates of Tobacco and Nicotine Containing Products Use in a Sample of United States Air Force Trainees. Nicotine and Tobacco Research. 2016; 18(4):416-23.

ABSTRACTS (POSTER AND ORAL PRESENTATIONS): 1. Daily LR, Gordon J, Ulm M, ElNaggar AC, Tillmanns TD. Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control? Poster Presentation. Annual Meeting of the Society of Gynecologic Oncology; 2017 March; National Harbor, MD.

ABSTRACTS (POSTERS AND ORALPRESENTATIONS): 1. Christiansen M, Francillon LI, Ikwuezunma GB, Gordon J, Goedecke PJ, Bursac Z, Detti L. Prediction of First Trimester Miscarriage by Ultrasound. Fertility and Sterility; 108(3): e383-e384.

2. Daily LR, Haygood CW, Mitchell CJ, Crump KJ, Huh WK, Alvarez RD, Straughn JM. Effective Outpatient Management of Carboplatin Hypersensitivity Reactions in Gynecologic Oncology Patients. Featured Poster Presentation. Annual Meeting of the Society of Gynecologic Oncology; 2016 March; San Diego, CA.

2. Mari G, Bursac Z, Goedecke PJ, Aziz MM, Schennone MH, Dhinareddy R. Cesarean Section Reduced the Odds of Morbidity and Mortality Among Very Low Birthweight Infants. American Journal of Obstetrics and Gynecology; 2018; 218(1): S355.

Laura Detti

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Detti L, Fletcher NM, Saed GM, Sweatman T, Uhlmann RA, Pappo A, Peregrin-Alvarez I. Anti-Mullerian Hormone (AMH) for prevention of ovarian follicle depletion after pre-pubertal ovarian cortex xenotransplantation. J Assit Reprod Genet. 2018 Jul 25. doi: 10.1007/s10815-018-1260-z.

3. Aziz MM, Graham B, Bursac Z, Goedecke PJ, Dhinareddy R, Mari G. Is Maternal Magnesium Sulfate Administration Prior to Delivery and Independent Predictor of Survival in Neonates Who Weight Fewer than Five Hundred Grams? American Journal of Obstetrics and Gynecology; 2018; 218(1): S354-S355.

2. Detti L, Fletcher NM, Saed GM, Peregrin-Alvarez I, Uhlmann RA. Anti-Mullerian Hormone (AMH) may stall ovarian cortex function through modulation of hormone receptors other than the AMH receptor. Reprod Sci 2018;25(8):1218-1223. doi:10,1177/1933719117737850.

— 66 —

3. Detti L, Norwick H, Levi D’Ancona R, Wright A, Christiansen ME. Relevance of uterine subseptations: What length should warrant hysteroscopic resection? J Ultrasound Med. 2017; 36:757-765. doi: 10.7863/ultra.15.07073.

7. Detti L, Uhlmann RA, Levi D’Ancona R, Norwick H, Christiansen ME. Surgical correction of uterine subseptations re-establishes standard uterine cavity measurements. American Institute of Ultrasound in Medicine Annual Meeting; 2016 March 17-21; New York, NY.

4. Detti L. American Society of Reproductive Medicine Micro-Video: Diagnosis and Management of Intrauterine Septum: New Concepts. Online in ASRM website; https://www.asrm.org/resources/asrm-micro-videos/ diagnosis-and-management-of-intrauterine-septum/

8. Detti L, Fletcher NM, Uhlmann RA, Belotte J, Williams LJ , Saed GM. Exposure to recombinant Anti-Mullerian Hormone (AMH) downregulates ovarian follicle cells’ stemness potential in fresh and vitrified/thawed ovarian cortex. Society for Reproductive Investigation Annual Meeting; 2016 March 16-19; Montreal, Canada.

5. Roman R, Mussaratt N, Detti L. Ovarian Stimulatin in Poor Responders: Have We Made Progress? Curr Pharm Biotechnol 2017; 18(8):614-618. doi: 10.2174/1389201018666171 002132853.

INVITED LECTURES: 1. Detti L. (2018 December 5) Course Director of the pre-conference Ultrasound Course, Pelvic Anatomy and Gynecologic Surgery Symposium (Organized by the Cleveland Clinic and the University of Cincinnati). “Sonohysterogram: Technique and interpretation”, Las Vegas, NV.

6. Christiansen ME, Detti L. Clinically relevant female genital tract anomalies. Clinical Obstet Gynecol 2017; 60(1):18-26. doi: 0.1097/GRF.0000000000000258. 7. Detti L. Early Pregnancy Ultrasound. In Ultrasound Imaging in Reproductive Medicine: Advances in Infertility Work-up, Treatment and ART, Editors: Laurel Stadtmauer & Ilan TurKaspa, in press, Springer 2018.

2. Detti L. (2018 August 30) Mayo Clinic Lecture: “Fertility Preservation in female cancer patients: What are the options?”, Rochester, MN.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Roman RA, Peregrin-Alvarez I, Christiansen ME, Van de Velde N, Gordon J, Detti L. Effect of transcervical embryo transfer on placental location in patients undergoing assisted reproductive technology. American Society of Reproductive Medicine Annual Congress, October 8-10, 2018, Denver, CO.

3. Detti L. (2018 July 17-21) Contemporary Issues in Ob-Gyn. Annual Ob-Gyn Meeting sponsored by the University of Tennessee. “Fertility Preservation: What do we need to know?” and “Hirsutism and Polycystic Ovary Syndrome: Diagnosis and treatment”, Destin, FL. 4. Detti L. (2017 December 13) Course Director of the preconference Ultrasound Course, Pelvic Anatomy and Gynecologic Surgery Symposium (Organized by the Cleveland Clinic and the University of Cincinnati). “Ovarian masses: Refining your Management”, “Ultrasound Uses: Interactive Case Presentations What is Your Diagnosis?”, “Early Pregnancy Evaluation and Ectopic Pregnancy”, “3D in Evaluating Uterine Anomalies”, December 13, 2017, Las Vegas, NV.

2. Van de Velde N, Gordon J, Peregrin-Alvarez I, Roman RA, Christiansen ME, Detti L. Impact of environmental and nutritional factors on Recurrent Pregnancy Loss: A Geographic Information Systems Analysis. American Society of Reproductive Medicine Annual Congress, October 8-10, 2018, Denver, CO. 3. Peregrin-Alvarez I, Roman RA, Van de Velde N, Christiansen ME, Gordon J, Detti L. Concomitant hypothyroidism does not impact ovarian reserve parameters in polycystic ovary syndrome. American Society of Reproductive Medicine Annual Congress, October 8-10, 2018, Denver, CO.

5. Detti L. (2017 October 30) Chair and organizer of the IRMSIG Postgraduate Course: Ultrasound imaging to improve fertility and pregnancy outcomes. American Society of Reproductive Medicine Annual Meeting. “Ultrasound Monitoring of the early pregnancy: normal vs. abnormal pregnancy”, “Uterine subseptations and their role in infertility and early pregnancy loss”, “Clinical Case Presentations”, October 30, 2017, San Antonio Texas.

4. Gordon J, Van de Velde N, Peregrin-Alvarez I, Christiansen ME, Detti L. Feasibility of placental location prediction by early ultrasound.American Institute of Ultrasound in Medicine Annual Meeting, March 24-28, 2018, New York, NY. 5. Christiansen ME, Peregrin-Alvarez I, Francillon L, Gordon J, Detti L. Uterine subseptations and indication for surgical correction: a comparison of three systems.American Institute of Ultrasound in Medicine Annual Meeting, March 24-28, 2018, New York, NY.

6. Detti L. (2017 October 30) Interactive session: Early pregnancy Ultrasound. American Society of Reproductive Medicine Annual Meeting; San Antonio TX. 7. Detti L. (2017 October 30) Round Table luncheon: Ultrasound Evaluation of Uterine Septum-Which Patients are Surgical Candidates? American Society of Reproductive Medicine Annual Meeting; San Antonio TX.

6. Detti L, Fletcher NM, Saed GM, Uhlmann RA, Tobiasz AM, Williams LJ. Anti-Mullerian Hormone (AMH) for prevention of tissue activation after vitrified/thawed ovarian cortex xenotransplantation. American Society of Reproductive Medicine Annual Meeting; 2016 October 17-20; Salt Lake City, UT. Fertil Steril 2016.

8. Detti L. (2017 July 25-29) Contemporary Issues in Ob-Gyn. Annual Ob-Gyn Meeting sponsored by the University of Tennessee. “Diagnosis and treatment of intrauterine septum: New concepts” and “A practical approach to Polycystic Ovary Syndrome”, Destin, FL.

— 67 —

9. Detti L. (2017 March 27) Postgraduate Course speaker: Ultrasonographic diagnosis of congenital female genital tract anomalies. American Institute of Ultrasound in Medicine Annual Meeting; Orlando, FL. 10. Detti L. (2016 July 26-30) Contemporary Issues in Ob-Gyn. Annual Ob-Gyn Meeting sponsored by the University of Tennessee. “Pregnancy after malignancy: Options in fertility preservation” and “Ultrasonographic diagnosis of congenital female genital tract anomalies”, Destin, FL. 11. Detti L. (2016 January 17) Grand Rounds MethodistLeBonheur Hospital: ‘Fertility Preservation; Memphis, TN. AWARDS: 1. 2018 Health Care Heroes Finalist Memphis Business Journal Magazine 2. 2018 ASRM Star Award For 10 years of contributions to the ASRM annual conference 3. 2018 UTHSC Mentor Resident Paper Day 1stand 2ndplace 4. Detti L. ASRM Star Award For 10 years of contributions to the ASRM annual conference (2017) 5. Detti L. ASRM Star Award For 10 years of contributions to the ASRM annual conference (2016) 6. 2017 UTHSC Mentor Resident Paper Day 2ndplace

Jose Duncan

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Salama-Bello R, Duncan J, Howard SL, Song J, Schenone MH. Placenta location and the Development of hypertensive disorders of pregnancy. J Ultrasound Med. 2018 May 6. doi: 10.1002/jum.14681. [Epub ahead of print] 2. Schenone M, Zeibarth S, Duncan J, Stokes L, Hernandez A. Effects of a proposed quality improvement process in the proportion of the reported ultrasound findings unsupported by stored images. J Matern Fetal Neonatal Med. 2018. Doi: 10.1080/14767058.2018.143258.

3. Duncan J, Schenone MH, Mari G. Technique for bilateral salpingectomy at the time of Cesarean delivery: a case series. Contraception. 2017; 95 (5): 509-11. PMID: 2863747

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Duncan J, Aziz MM, Tobiasz AM, Dorset KM, Bursac Z, Mari G, Schenone MH. Fetal Pulmonary Artery Acceleration/ ejection Time Predicts Respiratory Complications in PPROM. Accepted at the American Institute of Ultrasound in Medicine Annual Convention; 2018 March; New York, NY. 2. Duncan J, Rios-Doria E, Tobiasz AM, Bursac Z, Schenone MH, Mari G. Postpartum Magnesium Sulfate Effect on the Uterine Artery Pulsatility Index. Accepted at the American Institute of Ultrasound in Medicine Annual Convention; 2018 March; New York, NY. 3. Salama-Bello R, Duncan J, Howard SL, Sung J, Schenone MH. Placental Location and Hypertensive Disorders of Pregnancy. Accepted at the American Institute of Ultrasound in Medicine Annual Convention; 2018 March; New York, NY. 4. Duncan J, Dorset KM, Aziz MM, Tobiasz AM, Bursac Z, Schenone MH. Are Histologic Signs of FIRS Associated with Shorter Latency in Pregnancies Complicated by PPROM?. Accepted at the Society for Reproductive Investigation Annual Meeting; 2018 March; San Diego, CA. 5. Duncan J, Jones HL, Aziz MM, Tobiasz AM, Mari G. Is Bilateral Salpingectomy Associated with Higher Rate of Surgical Complications during Cesarean Delivery? Accepted at the Society for Reproductive Investigation Annual Meeting; 2018 March; San Diego, CA. 6. Duncan J, McDonald EJ, Schenone MH. Does Left Ventricular Hypertrophy Increases the Risk of Adverse Outcomes in Pregnancies with Chronic Hypertension? Accepted at the Society for Reproductive Investigation Annual Meeting; 2018 March; San Diego, CA. 7. Duncan J, Tobiasz AM, Rios-Doria E, Schenone MH, Mari G. Changes in the uterine artery Doppler after delivery in hypertensive disorders of pregnancy may be different in patients with severe features. Society for Maternal-Fetal Medicine Annual Meeting; 2018 January; Dallas, TX. 8. Duncan J, Tobiasz, AM, Thompson, R, Mari G, Schenone MH. Pulmonary artery acceleration/ejection time as a predictor of neonatal respiratory complications in patients with preterm premature rupture of membranes. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 September; Vienna, Austria.

4. Tobiasz AM, Duncan J, Sullivan RD, Tate DL, Dopico AM, Bukiya AN, Mari G. The effect of prenatal alcohol exposure on fetal growth and cardiovascular parameters in a baboon model of pregnancy. Reprod Sci. 2017 Jan 1:1933719117734317. doi: 10.1177/1933719117734317

9. Duncan J, Tobiasz AM, Thompson R, Schenone MH, Mari G. Uterine artery pulsatility index in pregnancies complicated by preterm premature rupture of membranes as predictor of placental vascular complications. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 September; Vienna, Austria.

5. Schenone M, Duncan J, Levi-Dancona R, Mari G. Doppler ultrasonography for the diagnosis and management of fetal anemia, hydrops, and fetal lung maturity. In: Fleischer’s Sonography in Obstetrics & Gynecology textbooks and teaching cases 8th ed. New York, NY. McGraw Hill Education; 2017.

10. Duncan J, Tobiasz, AM, Thompson R, Schenone MH, Mari G. The cerebroplacental ratio does not appear to predict severe neonatal outcomes in preterm premature rupture of membranes. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 September; Vienna, Austria.

— 68 —

11. Duncan J,Tobiasz, AM, Rios-Doria E, Schenone MH, Mari G. Prediction of adverse outcomes in women with hypertensive disorders of pregnancy near term utilizing the uterine artery pulsatility index. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 September; Vienna, Austria.

22. Duncan J, Tobiasz AM, Apostolakis-Kyrus K, Tate DL, Gomez LM, Mari G. Validation of a mathematical model to estimate actual hemoglobin value in fetuses at risk for Anemia. 2016. Society of Reproductive Investigation Annual Meeting; 2016 March; Montreal, Canada. INVITED LECTURES: 1. Duncan, J. (2017 August) Ultrasound: Hand On (obstetrics). 31st Annual Contemporary Issues in Obstetrics and Gynecology; Sandestin, FL.

12. Duncan J; Tobiasz AM; Schenone MH; Mari, G. Uterine Artery Flow Velocity Waveforms pattern before and after delivery in hypertensive disorders of pregnancy. 2017 American Institute of Medicine Annual Convention; 2017 March; Orlando, FL.

2. Duncan, J. (2016 October) Just Images. Fourth Annual Fetal & Neonatal Imaging: Analysis Across a Life Border. 2016 October; Memphis, TN.

13. Duncan J, Tobiasz AM, Tate D, Schenone MH. Does placental location affect fetal fraction obtained for cell free DNA screening for aneuploidies?. American Institute of Medicine Annual Convention; 2017 March; Orlando, FL.

Patricia J. Goedecke

PEER REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Mari, G, Bursac, Z, Goedecke, PJ, & Dhanireddy, R. Factors Associated With Improvements in Mortality and Morbidity Rates of Very-Low-Birth-Weight Infants: A Cohort Study. Global Pediatric Health. 2018; 5, 2333794X18765366.

14. Schenone MH, Ziebarth S, Stokes L, Hernandez A, Duncan J. Evaluation of the effects of a proposed quality improvement process in the proportion of reported findings unsupported by stores images?. American Institute of Medicine Annual Convention; 2017 March; Orlando, FL.

2. Little, MA, Klesges, RC, Bursac, Z, Ebbert, JO, Halbert, JP, Dunkle, AN, Colvin, L, Goedecke, PJ and Weksler, B. Why Don’t Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer Survivors. Journal of cancer prevention. 2018; 23(1), p.44.

15. Duncan J, Chotai PN, Slaggle AK, Huang EY, Talati AJ, Schenone MH. Delivery at Academic Institutions may Improve Cesarean Delivery Rates in Patients with Gastroschisis. Presented at the Society of Reproductive Investigation Annual Meeting; 2017 March; Orlando, FL. 16. Tobiasz A, Duncan J, Sullivan R, Tate, DL, Dopico A, Bukiya AN, and Mari G. Effect of maternal binge drinking on the fetal circulation. Presented at the Society for Reproductive Investigation Annual Meeting; 2017 March; Orlando, FL.

3. Bursac Z, Goedecke PJ, Little M, & Klesges R. Cumulative vs. adjacent-category logits: Readiness to quit smoking among cancer survivors. Abstract at Joint Statistical Meetings (JSM), Statistics in Epidemiology section. 2017; Baltimore, MD: American Statistical Association. ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Aziz MM, Graham B, Bursac Z, Goedecke PJ, Dhanireddy R, Mari G. Is cesarean delivery an independent predictor of survival in neonates who weigh fewer than five hundred grams? Abstract published in the proceedings of the 38th annual meeting of the Society for Maternal-Fetal Medicine; 2018; Dallas, TX.

17. Tobiasz A, Duncan J, Detti L, and Gomez L. Maternal and fetal fetuin-A levels in pregnancies complicated by preeclampsia. Presented at the Society for Reproductive Investigation Annual Meeting; 2017 March; Orlando, FL. 18. Duncan J, Bryant CS, Shah JP, Solomon LA, Schimp VL, Malone JM, Morris RT. (2007). Median survival after initiation of palliative paracentesis in patients with recurrent ovarian cancer. Society of Gynecology Oncologic Annual Meeting; 2017 March; San Diego, CA.

2. Aziz MM, Graham B, Bursac Z, Goedecke PJ, Dhanireddy R, Mari G. Is maternal magnesium sulfate administration prior to delivery an independent predictor of survival in neonates who weigh fewer than five hundred grams? Abstract published in the proceedings of the 38th annual meeting of the Society for Maternal-Fetal Medicine; 2018; Dallas, TX.

19. Tobiasz AM; Duncan J; Mari G; Detti, L. Fetal insulin resistance and maternal polycystic ovary syndrome. Society for Maternal-Fetal Medicine Annual Meeting; 2017 January; Las Vegas, NV.

3. Mari G, Bursac Z, Goedecke PJ, Aziz MM, Dhanireddy R. Cesarean section reduces the odds of morbidity and mortality among very low birthweight infants. Abstract published in the proceedings of the 38th annual meeting of the Society for Maternal-Fetal Medicine; 2018; Dallas, TX.

20. Pranit N. Chotai, MD; Anna Slagle, MD; Jose Duncan, MD; Ajay J. Talati, MD; Mauro Schenone, MD; Max R Langham Jr, MD; Eunice Y. Huang, MD, MS. Are Gastroschisis Patients at risk for Intestinal Ischemia Identifiable at the Time of Initial Neonatal Evaluation?. American Academy of Pediatrics Annual Meeting; 2016 October; San Francisco, CA.

4. Mari G, Bursac Z, Goedecke PJ, Dhanireddy R. Factors associated with the reduction in odds of morbidity and mortality among very low birthweight infants. Abstract published in the proceedings of the 38th annual meeting of the Society for Maternal-Fetal Medicine; 2018; Dallas, TX.

21. Duncan J, Vallarino, Schenone MH, Tobiasz AM, Talati A. Obstetrical Characteristics of Patients with Hypoxic Ischemic Encephalopathy Undergoing Hypothermia Therapy. Society of Reproductive Investigation Annual Meeting; 2016 March; Montreal, Canada.

— 69 —

INVITED LECTURES: 1. (2016) Bursac Z, Goedecke PJ, Little M, & Klesges R. Cumulative vs. adjacent-category logits: Readiness to quit smoking among cancer survivors. Abstract presented at Joint Statistical Meetings (JSM), Statistics in Epidemiology section. Baltimore, MD: American Statistical Association.

9. Duncan J, Schenone M, and Mari G. Technique for bilateral salpingectomy at the time of Cesarean delivery, a case series. Contraception. 2017 May; 95(5):509-511. 10. Schlabritz-Loutsevitch N, Apostolakis-Kyrus K, Krutilina R, Hubbard G, Kocak M, Janjetovic Z, Sathanandam S, Slominski A, Mari G, Dick Jr. E. Pregnancy-driven cardiovascular maternal mir29 plasticity in obesity. J Med Primatol. 2016; 12236: 1-7.

Pallavi Khanna

INVITED LECTURES: 1. Khanna P. (2017 August) Essure- from insertion, controversies and removal. 31st Annual Contemporary Issues in Obstetrics and Gynecology Conference. Destin, FL.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Duncan J, Rios-Doria E, Tobiasz A, Schenone M, Mari G. Postpartum Magnesium Sulfate Effect on the Uterine Artery Pulsatility Index. AIUM annual conference; 2018 March 27; New York, NY. (Oral presentation)

2. Khanna P. (2017 August) Updates in Contraception. 31st Annual Contemporary Issues in Obstetrics and Gynecology Conference. Destin, FL.

2. Duncan J, Jones HL, Aziz MM, Tobiasz AM, Mari G. Is Bilateral Salpingectomy Associated with Higher Rate of Surgical Complications during Cesarean Delivery? Society for Reproductive Investigation Annual Meeting; 2018 Mar 6-10; San Diego, CA.

Giancarlo Mari

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Rogers AJG, Harper LM, Mari G. A Conceptual Framework for the impact of Obesity on Risk of Cesarean Delivery. AM J Obstet Gynecol 2018: doi: 10.1016/j.ajog.2018.06.006. (Epub ahead of print.)

3. Aziz MM, Graham B, Bursac Z, Goedecke T, Dhanireddy R, Mari G. Is Cesarean Delivery an Independent Predictor of Survival in Neonates who weigh fewer than five hundred grams? 65th Annual Scientific Meeting of the Society for Reproductive Investigation; 2018 Mar 6-10; San Diego, CA.

2. Tobiasz A, Duncan J, Bursac Z, Sullivan R, Tate D, Dopico A, Bukiya A, Mari G. The Effect of Prenatal Alcohol Exposure on Fetal Growth and Cardiovascular Parameters in a Baboon Model of Pregnancy. Reproductive Sciences 2018 July; 25 (7):1116-1123

4. Willingham LG, Schenone M, Samson FD, Mari G, Tate DL. Pravastatin may attenuate the expected cardiac Changes in hypertensive pregnant rats. Am J Obstet Gynecol; 2018; 218(1)(Suppl1):S196-S19.

3. Duncan J, Tobiasz A, Rios-Doria E, Bursac Z, Schenone M, Mari G. Uterine Artery Flow Velocity Waveforms Before and After Delivery in Hypertensive Disorders of Pregnancy near term. 2018. June. Hypertension 2018; 37:131-136.

5. Willingham LG, Schenone M, Samson FD, Mari G, Tate DL. Pravastatin prevents blood pressure elevations in hypertensive pregnant rats. Am J Obstet Gynecol; 2018; 218(1)(Suppl1):S77.

4. Bukiya, A, North K, Tobiasz A, Sullivan R, Bursac Z, Duncan J, Sullivan P, Davison S, Tate D, Barnett S, Mari G. Prenatal alcohol exposure, anesthesia, and fetal loss in baboon model of pregnancy. 2018 June. (In Press Journal of Drug and Alcohol Research.)

6. Samson FD, Willingham LG, Mari G, Tate DL, Schenone M. Effects of Selective Reduced Uterine Perfusion Pressure on organs commonly affected by preeclampsia. Am J Obstet Gynecol; 2018; 218(1)(Suppl 1):S201-S202.

5. Mari G, Bursac Z, Goedecke P J, Dhanireddy R. Factors associated with improvements in mortality and morbidity rates of very low birth weight infants at a regional perinatal center from 2004-2015: a cohort study. Global Pediatric Health 2018 Feb; 5:1-10.

7. Duncan J, Tobiasz AM, Rios-Doria E, Schenone MH, Mari G. Changes in the uterine artery Doppler after delivery in hypertensive disorders of pregnancy may be different in patients with severe features. Am J Obstet Gynecol; 2018;218(1) (Suppl 1):S157-S158.

6. Schlabritz-Loutsevitch N, Maher J, Sullivan R, Mari G, Schenone M, Cohen H, Word R, Hubbard G, Dick Jr E. Parturition in baboons. Scientific Reports. 2018 Jan; 1-6.

8. Mari G, Bursac Z, Goedecke PJ, Aziz M, Dhanireddy R. Cesarean section reduces the odds of morbidity and mortality among very low birthweight infants. Poster presentation at the Society for Maternal Fetal Medicine 38th Annual Pregnancy Meeting; 2018 Feb 2; Dallas, TX.

7. Schenone M, Duncan J, Levi-Dancona R, Mari G. Doppler ultrasonography for the diagnosis and management of fetal anemia, hydrops, and fetal lung maturity. In: Fleischer’s Sonography in Obstetrics & Gynecology textbooks and teaching cases 8th ed. New York, NY. McGraw Hill Education; 2017.

9. Tate D, Grese L, Schenone M, Mari G, Ahokas R. 898: Cardiac effects of hypertensive disease in pregnant rats. Poster Presentation at the Society for Maternal Fetal Medicine Annual Meeting; Jan 29- Feb 3; Dallas, TX. American Journal of Obstetrics and Gynecology; 2018; 21(1)(Suppl):S513.

8. Seleverstov O, Tobiasz A, Jackson JS, Sullivan R, Ma D, Sullivan JP, Davison S, Akkhawattanangkul Y, Tate DL, Costello T, Barnett S, Li W, Mari G, Dopico AM, Bukiya AN. Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via endocannabinoid receptors. Alcohol. 2017 Jun; 61:51-61.

10. Duncan J, Tobiasz, AM, Rios-Doria E, Schenone MH, Mari G. Prediction of adverse outcomes in women with hypertensive disorders of pregnancy near term utilizing the uterine artery pulsatility index. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 Sept 16-19; Vienna, Austria. — 70 —

11. Duncan J, Tobiasz, AM, Thompson R, Schenone MH, Mari G. The cerebroplacental ratio does not appear to predict severe neonatal outcomes in preterm premature rupture of membranes. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 Sept 16-19; Vienna, Austria.

5. Mari G. (2018 September) Clinical Applications of Middle Cerebral Artery Doppler. Advanced Sonography Symposium in Ob/Gyn. Harvard Medical School. Boston, MA. 6. Mari G. (2018 September) Role of Ultrasound and Doppler for IUGR. Advanced Sonography Symposium in Ob/Gyn. Harvard Medical School. Boston, MA.

12. Duncan J, Tobiasz AM, Thompson R, Schenone MH, Mari G. Uterine artery pulsatility index in pregnancies complicated by preterm premature rupture of membranes as predictor of placental vascular complications. International Society of Ultrasound in Obstetrics and Gynecology annual convention; 2017 Sept 16-19; Vienna, Austria.

7. Mari G. (2018 May 18). Doppler application in Obstetrics. 2018 Watson Lectureship guest speaker. Mayo Clinic. Rochester, Minnesota. 8. Mari G. (2017 November 7). Diagnosis and Management of RCIU that We Lack. XXII Latin American Congress of Obstetrics and Gynecology FLASOG 2017. Cancun, Mexico.

13. Tobiasz A, Duncan J, Sullivan R, Tate D, Dopico A, Bukiya A, Mari G. Effect of maternal binge drinking on the fetal circulation. Poster presentation at the Society for Reproductive Investigation; 2017 Mar 15-18; Orlando, FL.

9. Mari G. (2017 November 6). Obesity and Pregnancy, What is the challenge? XXII Latin American Congress of Obstetrics and Gynecology FLASOG 2017. Cancun, Mexico.

14. Tobiasz A, Duncan J, Mari G, Detti L, Gomez G. Maternal and fetal fetuin-A levels in pregnancies complicated by preeclampsia. Poster presentation at the Society for Reproductive Investigation; 2017 Mar 15-18; Orlando, FL.

10. Mari G. (2017 November 6). Practical Use of US Doppler in Obstetrics. XXII Latin American Congress of Obstetrics and Gynecology FLASOG 2017. Cancun, Mexico.

15. Tobiasz A, Duncan J, Mari G, Detti L. Fetal insulin resistance and maternal polycystic ovary syndrome. Poster presentation at the Society for Maternal Fetal Medicine Annual Meeting; 2017 Jan 23-28; Las Vegas, NV. American Journal of Obstetrics and Gynecology; 2017; 216(1)(suppl 1):S447-S448.

11. Mari G. (2017 October 20). Doppler of the IUGR fetus: What have we learned? The 3rd Annual Detroit OB/GYN Ultrasound Symposium. Detroit, Michigan. 12. Mari G. (2017 October 20). Doppler in Obstetrics: Basic Concepts and Clinical Applications. The 3rd Annual Detroit OB/GYN Ultrasound Symposium. Detroit, Michigan.

16. Duncan J, Tobiasz A, Apostolakis-Kyrus K, Gomez LM, Tate D, and Mari G. Validation of a mathematical model to estimate the hemoglobin in fetuses at risk for anemia, Society for Gynecological Investigation Annual Meeting; 2016 Mar; Montreal, Canada.

13. Mari G. (2017 June 15). The Mason C. Andrews Endowed Lecture: Health Care Systems and Maternal/Infant Mortality. Resident Research Paper Day. Eastern Virginia Medical School, Department of Obstetrics and Gynecology. Norfolk, Virginia.

17. Tobiasz A, Gomez LM and Mari G. The Doppler transitional phase in severely premature IUGR fetuses. American Institute of Ultrasound in Medicine Annual Convention; 2016 Mar; New York, NY.

14. Mari G. (2017 May 14-17). Italians in the world. “The experience of a lifetime.” XX Congresso Nazionale SIEOG. Societa Italiana di Ecografia Osterica e Ginecologica e Metodologie Biofisiche. Florence, Italy.

18. Tobiasz A, Samson J, Schenone M, Meyer N, Gomez LM, and Mari G. Middle cerebral artery pulsatility index in fetuses with congenital cardiac abnormalities. Society for Maternal Fetal Medicine Meeting; 2016 Feb 6; Atlanta, GA.

15. Mari G. (2017 May 14-17). Management of Multiple Gestation. XX Congresso Nazionale SIEOG. Societa Italiana di Ecografia Osterica e Ginecologica e Metodologie Biofisiche Florence, Italy.

INVITED LECTURES: 1. Mari G. (2018 November). Applications of Doppler ultrasonography in obstetrics. 11th Congress of Maternal Fetal Medicine and Perinatology Society of Turkey Association. Istanbul, Turkey.

16. Mari G. (2017 April 28). Quality in Obstetrics. 2017 Summit of Obstetric Safety Management & Simulation Training in Ob/ Gyn. Zhengzhou University. Zhengzhou, China. 17. Mari G. (2017 April 28). The Diagnosis of Fetal Anemia with Doppler Ultrasonography. 2017 Summit of Obstetric Safety Management & Simulation Training in Ob/Gyn. Zhengzhou University. Zhengzhou, China.

2. Mari G. (2018 November). Diagnosis and management of the early growth restricted fetus. 11th Congress of Maternal Fetal Medicine and Perinatology Society of Turkey Association. Istanbul, Turkey.

18. Mari G. (2017 April 28). Multiple Gestations. 2017 Summit of Obstetric Safety Management & Simulation Training in Ob/ Gyn. Zhengzhou University. Zhengzhou, China.

3. Mari G. (2018 November). Current diagnosis and management of red cell alloimmunization. 11th Congress of Maternal Fetal Medicine and Perinatology Society of Turkey Association. Istanbul, Turkey.

19. Mari G. (2017 April 28). Doppler Ultrasonography: the basics and beyond. 2017 Summit of Obstetric Safety Management & Simulation Training in Ob/Gyn. Zhengzhou University. Zhengzhou, China.

4. Mari G. (2018 September) Uterine Artery Doppler-Should we be using it? Advanced Sonography Symposium in Ob/Gyn. Harvard Medical School. Boston, MA.

— 71 —

Linda Moses

20. Mari G. (April 27). Diagnoses and Management of IUGR Fetuses. 2017 Summit of Obstetric Safety Management & Simulation Training in Ob/Gyn. 1st Affiliated Hospital. Zhengzhou University. Zhengzhou, China.

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. S hephard, C., & Moses-Simmons, L. Cultural Competency. In M. Olsen & L. Keder (Eds.), Gynecologic Care. 2018; 411-420. Cambridge: Cambridge University Press. doi:10.1017/9781108178594.044

21. Mari G. (2017 March 30). Current and future applications of Doppler Ultrasonography in Obstetrics. Beaumont Hospital, Department of Obstetrics and Gynecology Grand Rounds. Royal Oak, Michigan.

Tiffany Redfern

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. T.M. Redfern, K. DeLeon, L. Levine, G. Richardson. Sterilization Procedures: A Missed Opportunity to Prevent Cancer in Patients Treated at US Residency Programs? ACOG Annual Clinical and Scientific Meeting; 2017 May; Austin, TX. (Poster presentation)

22. Mari G. (2017 February 24). IUGR: Diagnosis and Management: What have we learned? 4th Annual Erlanger Health System Ob/Gyn Potpourri. Chattanooga, TN. 23. Mari G. (2017 February 24). Doppler in Obstetrics: Basic Concept & Clinical Applications. 4th Annual Erlanger Health System Ob/Gyn Potpourri. Chattanooga, TN. 24. Mari G. (2016 October 18). Health Care Maternal /Infant Mortality. Department of Obstetrics and Gynecology, University of Tennessee Health Science Center. Memphis, TN.

2. La Rosa, M., Omere, C., Redfern, T., Abdelwahab, M., Spencer, N., Olson, G., Saade, G., Saad, A. The Impact of Low Dose verses High-Dose Antibiotic Prophylaxis Regimens on Surgical Site Infection Rates after Cesarean Delivery. Obstetrics and Gynecology; 2017 February; submitted for publication.

25. Mari G. (2016 March 19). The use of middle cerebral artery Doppler studies for the management of fetal anemia – pros. 2016 AIUM Annual Convention. New York, NY.

3. Redfern T., Wen T. Imaging in the Postpartum Mother. The Quality Improvement and Patient Safety Poster Session; 2017 May. (Poster presentation)

26. Mari G. (2016 March 19). The use of uterine artery Doppler studies for the prediction of preeclampsia – challenges. 2016 AIUM Annual Convention. New York, NY.

Mark Reed

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. C. Cosgrove, A. EINaggar, M. Ulm, R. Sarin, E. Hade, P. Blackburn , T. Tillmanns, M. Reed, D. Cohn, J. Fowler. Close vulvar cancer margins are not strongly associated with recurrence or survival. Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future. Society of Gynecologic Oncology Annual Meeting; 2017; National Harbor, MD.

MEETING/COURSES ORGANIZED: 1. Mari G. Course Organizer. 32nd Annual Contemporary Issues in Obstetrics and Gynecology. Destin, FL. July 17-21, 2018. 2. Mari G. Course Organizer. 31st Annual Contemporary Issues in Obstetrics and Gynecology. Destin, FL. August 1 – August 5, 2017.

2. Watson , CH, Tillmanns T, Ulm MA, Smiley L, Reed ME, Consolo S, Covington R. “The implementation of videoassisted genetic counseling for ovarian, fallopian and peritoneal cancer patients”. SGO Annual Meeting; 2016. (Plena Presentation)

3. Mari G. Course Co-Director. Fetal and Neonatal Imaging: Analyses across a Life Border. Memphis, TN. October 29-30, 2016.

Fernand Samson

4. Mari G. Course Organizer. 30th Annual Contemporary Issues in Obstetrics and Gynecology. Destin, FL. July 26 – July 30, 2016.

PEER –REVIEW PUBLICATIONS AND BOOK CHAPTERS: 1. Samson FD, Merriman AL, Tate D, Apostolakis-Kyrus K, Gomez LM. Adjuvant administration of 17-alpha-hydroxyprogesterone caproate in women with three or more second trimester pregnancy losses undergoing cervical cerclage is no more effective than cerclage alone. J. Perinat Med. 2017 July 28; Doi: 10.1515/jpm-2017-0074. [Epub ahead of print] PMID: 28753545

AWARDS: 1. Mari G. Inside Memphis Business Magazine: Innovations Award for OB F.A.S.T. September 20, 2017 2. Mari G. Honorary member of the Italian Society of Ultrasound in Obstetrics and Gynecology. Florence Italy, May 14-17 (2017). The experience of a lifetime.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Samson FD, Willingham LG, Mari G, Tate DL, Schenone M. Effects of Selective Reduced Uterine Perfusion Pressure on organs commonly affected by preeclampsia. Society of Maternal Fetal Medicine Annual Pregnancy Meeting; 2018; Dallas, TX.

3. Mari G. Selected as one of America’s Top Doctors (2016-18) 4. Mari G. Received the 2017 America’s Most Honored Professionals Award 5. Mari G. Marquis Who’s Who in America (2017)

2. Willingham LG, Schenone M, Samson FD, Mari G, Tate DL. Pravastatin prevents blood pressure elevations in hypertensive pregnant rats. Society of Maternal Fetal Medicine Annual Pregnancy Meeting; 2018; Dallas, TX.

6. Mari G. Selected as an Active Fellow of the American Gynecological and Obstetrical Society (2016) 7. Mari G. Tennessee Hospital Association Meritorious Service Award (2018)

— 72 —

3. Willingham LG, Schenone M, Samson FD, Mari G, Tate DL. Pravastatin may attenuate the expected cardiac changes in hypertensive pregnant rats. Society of Maternal Fetal Medicine Annual Pregnancy Meeting; 2018; Dallas, TX.

4. Samson J. Fetal abdomen-non-genitourinary, Fetal & Neonatal Imaging: Analyses Across a Life Border Conference; 2016 October; Memphis, TN. 5. Samson J. Septic shock and pregnancy. 30th Annual Contemporary Issues in Obstetrics and Gynecology Conference; 2016 July; Destin, FL.

4. Willingham LG, Schenone M, Samson FD, Mari G, Tate DL. Pravastatin prevents elevations in mean arterial blood pressure in hypertensive pregnant rats. Society for Maternal Fetal Medicine Annual Pregnancy Meeting; 2018; Dallas TX.

6. Samson J. Diabetes in pregnancy – updates. 30th Annual Contemporary Issues in Obstetrics and Gynecology Conference; 2016 July; Destin, FL.

5. Gomez LM, Sublette N, Wang JQ, Samson FD, Tate DL. HIV vertical transmission does not differ when using protein inhibitor or protease inhibitor antiretrovirals. ACOG annual Clinical and Scientific Meeting; 2018; Austin, TX.

7. Samson J. The IUGR fetus, how small is too small? 30th Annual Contemporary Issues in Obstetrics and Gynecology Conference; 2016 July; Destin, FL.

6. Samson FD. Diabetes in Pregnancy: Diagnosis, Management, and Controversies. 31st Annual Contemporary Issues in Obstetrics and Gynecology Conference; 2017 August; Sandestin, FL.

Mauro Schenone

PEER –REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Duncan J, Chotai P, Slagle A, Talati A, Huang E, Schenone M. Mode of delivery in pregnancies with gastroschisis according to delivery institution. J Matern Fetal Neonatal Med. 2018 Mar; 21:1-4. PMID 295627

7. Samson FD. Medical and Surgical Management of Postpartum Hemorrhage. 31st Annual Contemporary Issues in Obstetrics and Gynecology Conference; 2017 August; Sandestin, FL.

2. Schenone M, Ziebarth S, Duncan J, Stokes L, Hernandez A. Effects of a proposed quality improvement process in the proportion of the reported ultrasound findings unsupported by stored images. J Matern Fetal Neonatal Med. 2018 Feb; 5:1-4. PMID 29402162

8. Tate DL, Samson FD, Christiansen ME, Meyers L, Cashion K., Wang JQ, Santa Cruz M, Gomez LM. Comparison of two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV-) Infected Pregnant Women. Infectious Disease Week; 2017; San Diego, CA.

3. Duncan JR, Schenone M, Mari G. Technique for bilateral salpingectomy at the time of Cesarean delivery: A case series. Contraception. 2017 May; 95(5):509-511. PMID 28263747

9. Samson FD, Tate DL, Gomez, LM. Does 17-hydroxyprogesterone caproate affect fetal birth weight and biometry in singleton pregnancies? ACOG Annual Clinical and Scientific meeting; 2016; Washington, DC.

4. Schlabritz-Loutsevitch N, Maher J, Sullivan R, Mari G, Schenone M, Cohen HL, Word RA, Hubbard GB, Dick EJ Jr. Parturition in baboons (PAPIO SPP.). Sci Rep. 2018 Jan 19; 8(1):1174. PMID 29352119

AWARDS: 1. Samson, F. Outstanding Clinical Teaching by a Resident, Memphis, TN. (2016)

5. Schenone M, Duncan J, Levi-D’Ancona R, Mari G. Doppler ultrasonography for the diagnosis and management of fetal anemia, hydrops, and fetal lung maturity. In: Fleischer’s Sonography in Obstetrics &Gynecology textbooks and teaching cases 8th ed. New York, NY. McGraw Hill Education. 2017.

2. Samson, F. The Society of Maternal-Fetal Medicine Resident Award, Memphis, TN. (2016) 3. Samson, F. Women Services Choice Award, Memphis, TN. (2016)

Jacques Samson

6. Palacio M, Bonet-Carne E, Cobo T, Perez-Moreno A, Sabrià J, Richter J, Kacerovsky M, Jacobsson B, García-Posada RA, Bugatto F, Santisteve R, Vives À, Parra-Cordero M, Hernandez-Andrade E, Bartha JL, Carretero-Lucena P, Tan KL, Cruz-Martínez R, Burke M, Vavilala S, Iruretagoyena I, Delgado JL, Schenone M, Vilanova J, Botet F, Yeo GSH, Hyett J, Deprest J, Romero R, Gratacos E; Fetal Lung Texture Team. Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study. Am J Obstet Gynecol. 2017 Aug; 217(2):196.e1-196.e14. PMID

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Schlabritz-Loutsevitch N, German N, Ventolini G, Larumbe E, Samson, J. Fetal Syndrome of Endocannabinoid Deficiency (FSECD) in Maternal Obesity. Med Hypotheses. 2016 Nov; 96:35-38. doi: 10.1016/j.mehy.2016.09.021. Epub 2016 Sep 23. PMID: 27959272

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Samson J. Common Chromosome Disorders. American Congress of Obstetricians and Gynecologists Genomics Course; 2018 Feb; Cancun, Mexico.

7. Schenone M. Re: How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study. W. Ganzevoort, N. Mensing Van Charante, B. Thilaganathan, F. Prefumo, B. Arabin, C. M. Bilardo, et al., on behalf of the TRUFFLE Group. Ultrasound Obstet Gynecol; 2017; 49: 769-777. Ultrasound Obstet Gynecol. 2017 Jun; 49(6):694-695. PMID 28573769

2. Samson J. Diagnostic testing. American Congress of Obstetricians and Gynecologists Genomics Course; 2018 Feb; Cancun, Mexico. 3. Samson J. Cell Free DNA Screening. American Congress of Obstetricians and Gynecologists Genomics Course; 2018 Feb; Cancun, Mexico. — 73 —

8. Schlabritz-Loutsevitch NE, Comuzzie AG, Mahaney MM, Hubbard GB, Dick EJ, Kocak M, Gupta S, Carrillo M, Schenone M, Postlethwaite A, Slominski A. Serum Vitamin D Concentrations in Baboons (Papio spp.) during Pregnancy and Obesity. Comp Med. 2016; 66(2):137-42. PubMed PMID: 27053568

10. Mari G, Bursac Z, Goedecke PJ, Aziz M, Schenone M, Dhanireddy R. Cesarean section reduces the odds of morbidity and mortality among very low birthweight infants. Am J Obstet Gynecol; 2018; 218(1)(Suppl 1): S355. 38th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2018 January, Dallas, TX.

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Duncan JR, McDonald EJ, Schenone M. Does Left Ventricular Hypertrophy Increases the Risk of Adverse Outcomes in Pregnancies with Chronic Hypertension? Presented at the Society for Reproductive Investigation Annual Meeting; 2018 March; San Diego, CA.

11. Duncan JR, Tobiasz AM, Thompson R, Mari G, Schenone M. Pulmonary artery acceleration/ejection time as a predictor of neonatal respiratory complications in patients with preterm premature rupture of membranes. 27th World Congress on Ultrasound in Obstetrics and Gynecology; 2017 September 16-17; Vienna, Austria. (Oral presentation)

2. Duncan JR, Dorset KM, Aziz MM, Tobiasz AM, Bursac Z, Schenone M. Are Histologic Signs of FIRS Associated with Shorter Latency in Pregnancies Complicated by PPROM? Presented at the Society for Reproductive Investigation Annual Meeting; 2018 March; San Diego, CA.

12. Duncan JR, Talati A, Huang E, Schenone M. Delivery at academic institutions may improve maternal outcomes in pregnancies with gastroschisis. 64th Society for Reproductive Medicine Annual Meeting; 2017 March 15-18; Orlando, FL.

3. Duncan J, Aziz M, Tobiasz A, Dorsett K, Mari G, Schenone M. Fetal Pulmonary Artery Acceleration/Ejection Time Predicts Respiratory Complications in PPROM. AIUM annual conference; 2018 March 27; New York, NY. (Oral presentation)

13. Cardiac effects of hypertensive disease in pregnant rats. Tate D, Grese L, Schenone M, Mari G, Ahokas R. Am J Obstet Gynecol; 216(1)(Suppl): S513. 37th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2017 January 23-28; Las Vegas, NV.

4. Salama-Bello R, Duncan J, Song J, Howard S, Schenone M. Placental Location and Hypertensive Disorders of Pregnancy. AIUM annual conference; 2018 March 27; New York, NY. (Oral presentation)

14. Palacio M, Bonet-carne E, Cobo T, Perez-Moreno A, Sabria J, Richter J, Kacerovsky M, Jacobsson B, Garcia-posada R, Bugatto F, Santisteve R, Vives A, Parra-cordero M, Hernandez-andrade E, Bartha JL, Carretero-lucena P, Lit K, Cruz R, Burke M, Vavilala S, Iruretagoyena I, Delgado JL, Schenone M, Vilanova Joseph. Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study. Am J Obstet Gynecol; 216(1) (Suppl):S190. 37th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2017 January 23-28; Las Vegas, NV.

5. Duncan J, Rios-Doria E, Tobiasz A, Schenone M, Mari G. Postpartum Magnesium Sulfate Effect on the Uterine Artery Pulsatility Index. AIUM annual conference; 2018 March 27; New York, NY. (Oral presentation) 6. Grese L, Schenone M, Samson F, Mari G, Tate D. Pravastatin prevents blood pressure elevations in hypertensive pregnant rats. Am J Obstet Gynecol; 2018; 218(1)(Suppl 1):S77. 38th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2018 January; Dallas, TX. (Oral presentation)

15. Sosa-Olavarria A, Zurita-Peralta J, Prieto F, Schenone C, Schenone M. Fetal pulmonary artery pressure evaluation using Doppler. Am J Obstet Gynecol; 216(1)(Suppl):S154 S155. 37th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2017 January 23-28l Las Vegas, NV.

7. Duncan JR, Tobiasz AM, Rios-Doria EV, Bursac Z, Schenone M, Mari G. Changes in the uterine artery Doppler after delivery in hypertensive disorders of pregnancy may be different in patients with severe features. Am J Obstet Gynecol; 2018 January; 218(1)(Suppl 1): S157-S158. 38th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2018 January; Dallas, TX.

INVITED LECTURES: 1. Schenone, M. (2018 April). Fetal Therapy: The Good, The Bad and The Ugly. Kiwanis Club. Germantown, TN. 2. Schenone, M. (2017 December). Fetal Therapy: The Good, The Bad and The Ugly. Shelby County OBGYN Society Lecture. Memphis, TN.

8. Grese L, Schenone M, Samson F, Mari G, Tate D. Pravastatin may attenuate the expected cardiac changes in hypertensive pregnant rats. Am J Obstet Gynecol. 2018 January; 218(1) (Suppl):S196–S197. 38th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2018 January; Dallas, TX.

3. Schenone, M. (2017 November). Fetal Therapy: The Good, The Bad and The Ugly. Baptist Women’s Hospital Grand Rounds. Memphis, TN.

9. Samson F, Grese L, Mari G, Tate D, Schenone M. Effects of selective reduced uterine perfusion pressure on organs commonly affected by preeclampsia. Am J Obstet Gynecol; 2018; 218(1)(Suppl 1):S201–S202. 38th Annual Meeting-The Pregnancy Meeting, Society for Maternal Fetal Medicine; 2018 January; Dallas, TX.

4. Schenone, M. (2017 November). Interview for Medigest.com. ve (International) Update on Preeclampsia.

— 74 —

Claudette Shephard

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Tate, D, Sublette N, Samson F, Wang J, and L Gomez. HIV vertical transmission does not differ when using Protein Inhibitor or Integrase Inhibitor Antiretrovirals. Oral presentation at: The American College of Obstetricians and Gynecologists 2018 Annual Clinical and Scientific Meeting; 2018 April 27-30; Austin, TX.

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Shephard CJ, Moses-Simmons L.: Cultural Competence. In Gynecologic Care. Olsen M, KederL, editors. Cambridge University Press, Cambridge, 2018; 411-420. ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. White AB, Arnold SL, Shephard C. Do pediatric and internal medicine/pediatric residents do pelvic exams on adolescents? 2017 Southern Regional Meeting; 2017 February; New Orleans, LA. (Poster presentation.)

2. Tate, D, Miller A, Price J, Ramser K, Harris A, Moses-Simmons L, and L Gomez. Group Prenatal Care Model Use in PreGestational Diabetes. Oral Concurrent session – Society for Maternal-Fetal Medicine 38th Annual Meeting; 2018 Jan 29Feb 2; Dallas, TX.

INVITED LECTURES: 1. Shephard C. (2016 Feb 12). Primary Care needs of the Adolescent Girl – Resident Lecture – Texas Tech University, Health Sciences Center, Paul L. Foster School of Medicine.

3. Willingham L, Schenone M, Samson F, Mari G, and D Tate. Pravastatin prevents blood pressure elevations in hypertensive pregnant rats. Oral Concurrent session Society for Maternal-Fetal Medicine 38th Annual Meeting; 2018 Jan 29-Feb 2; Dallas, TX.

2. Shephard C. (2016 Feb 12). On Becoming a Woman: Common Problems in Pediatric Gynecology. Grand Rounds – Texas Tech University, Health Sciences Center, Paul L. Foster School of Medicine. Department of Ob/Gyn. El Paso, TX.

4. Samson F, Willingham L, Mari G, Tate, D and M Schenone. Effects of selective reduced uterine perfusion pressure on organs commonly affected by preeclampsia. Society for Maternal-Fetal Medicine 38th Annual Meeting; 2018 Jan 29Feb 2; Dallas, TX. (Poster Presentation)

Linda Smiley

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Watson CH, Ulm M, Blackburn P, Smiley L, Reed M, Covington R, Bokovitz L, Tillmanns T. Video assisted genetic counseling in patients with ovarian. fallopian and peritoneal carcinoma. Gynecol Oncol. 2016 Oct; l 43(1):109-12. doi: 10.1016/j.ygyno.2016. 07.094.

5. Willingham L, Schenone M, Samson F, Mari G, and D Tate. Pravastatin may attenuate the expected cardiac changes in hypertensive pregnant rats. Society for Maternal-Fetal Medicine 38th Annual Meeting; 2018 Jan 29-Feb 2; Dallas, TX (Poster Presentation)

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. C.H. Watson, M. Ulm, T. Tillmanns, M.E. Reed, L. Smiley and R. Covington. The implementation of video-assisted genetic counseling for ovarian, fallopian, and peritoneal cancer patients. Society of Gynecologic Oncology, 2016 March; San Diego, CA.

6. Tate D, Samson F, Christiansen M, Meyers L, Cashion K, Wang J, Santa Cruz M, and L Gomez. Comparison of two Antiretroviral Therapy Regimens In Human Immunodeficiency Virus (HIV-) Infected Pregnant Women. IDWeek 2017; 2017 Oct 4-8; San Diego, CA. (Poster Presentation)

Danielle Tate

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Samson FD, Merriman AL, Tate DL, ApostolakisKyrus K, Gomez, LM. Adjuvant administration of 17-hydroxyprogesterone caproate in women with three or more second trimester pregnancy losses undergoing cervical cerclage is no more effective than cerclage alone. J Perinat Med. 2018 Feb 23.

7. Tate, D, Grese, L, Schenone, M, Mari, G, and R Ahokas. Cardiac Effects of Hypertensive Disease in Pregnant Rats. Society for Maternal-Fetal Medicine 37th Annual Meeting; 2017, Jan 23-28; Las Vegas, NV.(Poster Presentation) 8. Tate, D, Christiansen, M, Meyers, L, Cashion, K, Wang, J, Samson, F, and L Gomez. Impact of different antiretroviral HIV regimens on obstetric and perinatal outcomes. Society for Reproductive Investigation 63th Annual Scientific Meeting; 2016 Mar 16-19; Montreal, Canada. (Poster Presentation)

2. Gomez L, Tate D, Jones R, Fuertes F, Ramanathan J. Pregnancy with uncorrected tetralogy of Fallot (TOF), pulmonary atresia and major aorto-pulmonary collateral arteries (MAPCA). Case Reports in Perinatal Medicine. 2018 Feb 13.

9. Gomez, L, Meyers, L, Christiansen, M, Salama, R, Cashion, K, Wang, J, and D Tate. Does body mass index impact the rate of HIV clearance in pregnant women receiving antiretrovirals?. Society for Reproductive Investigation 63th Annual Scientific Meeting; 2016 Mar 16-19; Montreal, Canada. (Poster Presentation)

3. Tobiasz A, Duncan JD, Bursac Z, Sullivan RD, Tate DL, Dopico AM, Bukiya AN, Mari G. The Effect of Prenatal Alcohol Exposure on Fetal Growth and Cardiovascular Parameters in a Baboon Model of Pregnancy. Reproductive Sciences. 2017 Oct; 1-8.

10. Shumaker, S, Phillips, O, Mari, G, and D. Tate. Non-Invasive Prenatal Screening: Is there usefulness beyond Fetal Aneuploidy? Society for Reproductive Investigation 63th Annual Scientific Meeting; 2016 Mar 16-19; Montreal, Canada. (Poster Presentation)

4. Seleverstov O, Tobiasz A, Jackson JS, Sullivan R, Ma D, Sullivan JP, Davison S, Akkhawattanangkul Y, Tate DL, Costello T, Barnett S, Li W, Mari G, Dopico AM, Bukiya AN. Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via endocannabinoid receptors. Alcohol. 2017 Jun; 61:51-61. doi: 10.1016/j.alcohol.2017.01.014. Epub 2017 May 18.

— 75 —

11. Shaw, A, Ulm, M, Wang, L, Tran, N, Tate, D, and N Meyer. Antenatal Testing in the Morbidly Obese Patient. Is it more harmful than helpful? Society for Reproductive Investigation 63th Annual Scientific Meeting; 2016 Mar 16-19; Montreal, Canada. (Poster Presentation)

7. C.H. Watson, M. Ulm, T. Tillmanns, M.E. Reed, L. Smiley and R. Covington. The implementation of video-assisted genetic counseling for ovarian, fallopian, and peritoneal cancer patients. Society of Gynecologic Oncology; 2016 March; San Diego, CA.

12. Naeem, U, Tate, D, Williams, L, Uhlmann, R, and L Gomez. Does Sickle Cell Trait affect adverse Pregnancy Outcomes? ACOG Annual Clinical and Scientific Meeting; 2016 May 14-17; Washington, DC. (Poster Presentation)

Michael Ulm

PEER-REVIEWED PUBLICATIONS AND BOOK CHAPTERS: 1. Ulm MA, Ginn DN, ElNaggar AC, Tillmanns TD, Reed KM, Watson C, Dedania SJ, Reed ME. “A Direct Comparison of Outcomes following Robotic-Assisted Staging and Open Laparotomy in patients with Early Stage Endometrioid Adenocarcinoma with Uterine Weight under 480 grams: A Retrospective Cohort.” Gynecology and Minimally Invasive Therapy. 2016; 5:25-29.

13. Veluswamy, H, Meyers, L, Sintim-Damoa, A, Copeland, J, Cohen, H, and Tate, D. Fetal MRI: A look into Its Utility in the Prenatal Diagnosis of Congenital Anomalies. Society for Reproductive Investigation 63th Annual Scientific Meeting; 2016 Mar 16-19; Montreal, Canada. (Poster Presentation)

2. Ulm MA, Watson CH, Vaddadi P, Wan JY and Santoso JT. Hypomagnesemia is prevelant in patients undergoing gynecologic surgery by a gynecologic oncologist.” International Journal of Gynecologic Cancer. 2016; 6(7):1320-1326.

Todd Tillmanns

ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. C. Cosgrove, A. ElNaggar, M. Ulm, R. Sarin, E. Hade, P. Blackburn, T. Tillmanns, M. Reed, D. Cohn, J. Fowler. Close vulvar cancer margins are not strongly associated with recurrence or survival. Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future. Society of Gynecologic Oncology Annual Meeting; 2017; National Harbor, MD.

3. Tillmanns TD, Mabe AR, Ulm MA, Lee D, Lowe P and Kumar S. “Vaginal Cuff Closure in Robotic Hysterectomy: A Randomized Controlled Trial Comparing Barbed Versus Standard Suture.” Journal of Gynecologic Surgery. 2016 July; 32(4): 215-219.

2. ElNaggar, R. Neff, M. Ulm, L. Lambrecht, U. Naeem, S. Pollock, J. Fowler, D. Cohn, F. Backes, T. Tillmanns. Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort. Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future. Society of Gynecologic Oncology Annual Meeting; 2017; National Harbor, MD.

4. Watson CH, Ulm MA, Blackburn P, Smiley L, Reed ME, Covington R, Bokovitz L, Tillmanns TD. “Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma.” Gynecologic Oncology. 2016 October; 143(1):109-12. ABSTRACTS (POSTERS AND ORAL PRESENTATIONS): 1. Ulm MA, Gordon JC, Daily LR, Watson CH, ElNaggar AC, Tillmanns TD. “Initial barriers to faith-based HPV education in the MidSouth.” Society of Gynecologic Oncology Annual Meeting; 2018 (Poster presentation)

3. C. Watson, A. ElNaggar, T. Tillmanns, M. Ulm. Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter? Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future. Society of Gynecologic Oncology Annual Meeting. National Harbor, MD. C. Coffman, A. ElNaggar, A. Talbot, C. Carr, S. Baum, T. Tillmanns. Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series. Society of Gynecologic Oncology Annual Meeting; 2017; National Harbor, MD.

2. Gordon JC, Blackburn P, Watson CH, Ulm MA, Daily LR, ElNaggar AC, Tillmanns TD. “Increased endometrial cancer recurrence in food deserts in the Southern United States by GIS analysis.” Society of Gynecologic Oncology Annual Meeting; 2018 (Poster Presentation) 3. Ulm MA, Ponnusamy S, ElNaggar AC, Narayanan R. “Identification and validation of Integrin-Linked Kinase (ILK) signaling as a therapeutic target for ovarian cancer.” AACR Annual Meeting; 2018. (Poster Presentation)

4. L. Daily, M. Ulm, A. ElNaggar, T. Tillmanns. Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control? Society of Gynecologic Oncology Annual Meeting; 2017; National Harbor, MD.

4. Ulm MA. “Minimally Invasive Surgery for Endometrial Cancer in Memphis, TN.” Memphis Robotic and Minimally Invasive Surgical Society Research Symposium; 2016.

5. Ulm MA, Mabe A, Lee D, Lowe MP, Kumar S, Tillmanns T. “Vaginal Cuff Closure in Robotic Hysterectomy: A Randomized Controlled Trial Comparing Barbed Versus Standard Suture.” 2016 Society of Ggynecologic Oncology Annual Meeting; 2016 San Diego, CA. (Poster Presentation)

5. Ulm MA, Watson CH, ElNaggar AC, Tillmanns TD. “A randomized controlled trial comparing the efficacy of perioperative celecoxib versus ketorolac for perioperative pain control.” Society of Gynecologic Oncology Annual Meeting. Focused Plenary Presentation; 2017.

6. Ulm MA, Ginn DN, Reed KM, Tillmanns TD, ElNaggar AC, Dedania SJ, Reed ME. “A Comparison of Progression Free Survival and Postoperative Outcomes for Early Stage Endometrioid Adenocarcinoma following Robotic-Assisted Staging and Open Laparotomy in the Community Setting.” 2016 Memphis Robotic and Minimally Invasive Surgical Society Research Symposium; 2016.

6. Ulm MA, ElNaggar AC, Tillmanns TD. “Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.” OncLive! Gynecologic Oncology Fellow’s Forum; 2018.

— 76 —

7. ElNaggar AC, Ulm MA, Blackburn P, Tillmanns TD, Reed M. “Close vulvar cancer margins are not strongly associated with recurrence or survival.” Society of Gynecologic Oncology Annual Meeting; 2017. (Featured Poster) 8. ElNaggar AC, Ulm MA, Tillmanns TD. “Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort.” Society of Gynecologic Oncology Annual Meeting; 2017. (Featured Poster) 9. Watson CH, ElNaggar AC, Tillmanns TD, Ulm MA. “Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter?” Society of Gynecologic Oncology Annual Meeting; 2017. (Featured Poster) 10. Daily LB, Ulm MA, ElNaggar AC, Tillmanns TD. “Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control?” Society of Gynecologic Oncology Annual Meeting; 2017. (Featured Poster) 11. Ulm MA, Mabe A, Lee D, Lowe MP, Kumar S, Tillmanns T. “Vaginal Cuff Closure in Robotic Hysterectomy: A Randomized Controlled Trial Comparing Barbed Versus Standard Suture.” Society of Gynecologic Oncology Annual Meeting; 2016. (Poster Presentation) 12. Watson, CH, Tillmanns T, Ulm MA, Smiley L, Reed ME, Consolos S, Covington R. “The implementation of videoassisted genetic counseling for ovarian, fallopian and peritoneal cancer patients.” SGO Annual Meeting; 2016. (Plenary Presentation) 13. Watson, CH, Tillmanns T, Ulm MA, Covington R. “Pedigree analysis of uterine papillary serous carcinoma patients.” Society of Gynecologic Oncology Annual Meeting; 2016. (Poster Presentation) 14. Ulm MA, Ginn DN, Reed KM, Tillmanns TD, ElNaggar AC, Dedania SJ, Reed ME. “A Comparison of Progression Free Survival and Postoperative Outcomes for Early Stage Endometrioid Adenocarcinoma following Robotic-Assisted Staging and Open Laparotomy in the Community Setting.” Memphis Robotic and Minimally Invasive Surgical Society Research Symposium; 2016. (Poster Presentation) 15. Ulm MA, Mabe A, Lee D, Lowe MP, Kumar S, Tillmanns TD. “Vaginal Cuff Closure in Robotic Hysterectomy: A Randomized Controlled Trial Comparing Barbed Versus Standard Suture.” Memphis Robotic and Minimally Invasive Surgical Society Research Symposium; 2016. (Poster Presentation)

Special thanks to: Randy Conway Adam Gaines David Glore LaTanya Spikenard Julienne Watkins

Prepared by Giancarlo Mari, MD, MBA, FACOG, FAIUM Professor and Chair and the Department of Obstetrics & Gynecology (2018)

DELIVERING EXCELLENCE IN WOMENâ&#x20AC;&#x2122;S HEALTH The University of Tennessee Health Science Center Department of Obstetrics & Gynecology

Special thanks to: Randy Conway Adam Gaines David Glore LaTanya Spikenard Julienne Watkins